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ABSTRACT 
The goal of my Ph.D. research is to develop controlled/living polymerization techniques 
of α-amino acid N-carboxyanhydrides (NCAs) and synthetic polypeptides based materials. 
Polypeptides are a class of emerging biomaterials receiving increasing interests for 
various applications including drug delivery, gene therapy, antimicrobial and tissue 
engineering. The ring-opening polymerization (ROP) of NCAs has long been 
demonstrated as a powerful technique for preparation of high molecular weight (MW) 
synthetic polypeptides in gram scale.  We developed a system utilizing organo-silicon 
amines, namely hexamethyldisilazane (HMDS) and N-trimethylsilyl (N-TMS) amines, 
for the controlled ROP of various NCAs.  Predicable MWs and narrow molecular weight 
distributions (MWDs) of homo- and block- polypeptides can be prepared via this 
methodology. Our mechanism study illustrated that the polymerization involves 
formation of trimethylsilyl carbamate (TMS-CBM) structure at the propagation center. In 
addition, the system allows facile end group and side-chain functionalization of the 
polypeptides and integration of NCA ROP with other polymerization techniques such as 
ring-opening metathesis polymerization (ROMP) to prepare hybrid polypeptides 
materials. Finally, we discovered a new type of ionic polypeptides with unusual helical 
stability and demonstrated that they have great potential for gene delivery and siRNA 
delivery applications. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Background 
1.1.1 Living Polymerizations: Control the uniformity of polymeric materials  
The past few decades have witnessed the emerging and thriving of utilizing 
polymeric biomaterials for various biomedical applications.[1-8] While the focus was 
initially on the structures and compositions of the materials, but now more emphasis is 
put on the functions of the materials through sophisticated design as.[9] In biological 
system, the functions of the biomolecules are often regulated by the delicate secondary or 
even more complex conformational structures. Notably, it is the high uniformity of the 
biomolecules that determines their conformational structures and then their biological 
functions. Similarly, More evidence suggests the significance of the uniformity of the 
materials on their ultimate functions and applications. The uniformity of the polymers in 
this case refers not only to the narrowness of molecular weight distribution (MWD), but 
also to the homogeneities of chemical structure regarding the tacticity, stereoregularity, 
sequence, morphology, and secondary and tertiary conformations.[10] Numerous studies 
demonstrated that high uniformity of the materials can improve the efficiency, potency, 
efficacy, clinical translation, and reproducibility.[11-18] Therefore, it is crucial to control 
the uniformity of every single component used in the materials from molecular level in 
order to get uniformed formulation, and reproducible and reliable therapeutic results.   
2 
 
Versatile polymerization methods, especially controlled/living polymerization 
techniques, such as atom-transfer radical polymerization (ATRP)[19], reversible addition-
fragmentation chain transfer polymerization (RAFT)[20-21], ring-opening polymerization 
(ROP)[17, 22], and ring-opening metathesis polymerization (ROMP)[23-24], provide us 
powerful tools to synthesize various polymeric materials with high efficiency and high 
uniformity. Controlled polymerizations also allow for the easy synthesis of various block 
polymers for self assembly and fine-tune of the conformational structures and properties 
of the polymers to better satisfy the delicate requirements for clinical and market 
purpose.[10]  
 
1.1.2 Ring-opening Polymerization of NCAs  
The ROP of α-Amino Acid N-carboxyanhydrides (NCAs) is the most common 
polymerization method for the synthesis of polypeptides in large scale and with high 
molecular weight (MW) (Scheme 1.1).[22] Although the NCA monomers have more than 
100-years of history and their polymerizations were extensively utilized throughout the 
1950s to 1970s, no controlled polymerization system was established until the late 
1990s.[25]  Conventional methods typically involve the use of amines as the initiators for 
the NCA polymerizations. Primary amines are usually considered to initiate the 
polymerization via nucleophilic ring opening of the NCA followed by growth of the 
polypeptides (Scheme 1.2a) through “Amine Mechanism”, while tertiary amines more 
likely function as a base to initiate the ROP of NCA through the so called “Activated 
Monomer” mechanism (AM).[22, 26] AM involves the deprotonation of the NCA ring in 
the initiation step (Scheme 1.2b), with the resulting deprotonated NCA acting as the 
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initiator.  However, neither primary amines nor tertiary amines adopt a single mechanism 
during the polymerization; the polymerizations switch back and forth between the amine 
mechanism and the activated monomer mechanism along with various side reactions. 
This inconsistency in reaction mechanism is believed to be the major cause of 
uncontrollable MWs and broad MWDs. 
 
The first living polymerization system was reported by Deming using 
organometallic catalysts in late 1990s. The two most successful catalysts, BpyNi(COD)  
(bipy = 2,2’-bipyridyl, COD = 1,5-cyclooctadiene) and (PMe3)4Co (PMe3 = 
trimethylphosphine), were shown to be suitable for the generation of homo- and block- 
polypeptides with controlled MW (Scheme 1.3).[27-28] Although functional, the catalysts 
are unstable and extremely sensitive to moisture, oxygen and the quality of solvent and 
monomer.  The complete removal of the metal from the polymers is another concern for 
the utilization of the materials in biological and pharmaceutical applications. To avoid 
using metal catalysts, Schlaad developed an ammonium initiation system that allowed the 
synthesis of polystyrene-block-poly(γ-benzyl-L-glutamate) (PS-b-PBLG) with low 
polydispersity.[29] However, this ammonium-initiated polymerization is extremely slow 
and can only be used for preparing low MW polypeptides. Hadjichristidis developed a 
high vacuum polymerization technique that allows for the synthesis of polypeptides with 
excellent controlled MW and low MWD, outperforming conventional polymerizations 
conducted in glove-box.[30] However, this polymerization requires the use of NCA 
monomers with exceptional purity. 
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1.1.3 Polypeptides as Biomaterials  
Polypeptides, due to their chemical diversity, biodegradability, and high 
biocompatibility, are emerging biomaterials possessing great potentials for various 
biomedical applications including drug delivery, gene delivery, bioadhesion, 
antimicrobial, and tissue engineering.[31-33] For example, Kataoka et al. showed that the 
block polymer of polyethylene glycol-block-poly(L-glutamic acid) (PEG-b-PLG) or 
polyethylene glycol-block-poly(L-aspartic acid) (PEG-b-PAsp) can effectively deliver the 
cis-platin and accumulate the drug in solid tumors (Lewis lung carcinoma cells).[34-35] 
Poly(L-glutamic acid)-paclitaxel conjugatesand Poly(L-glutamic acid)-camptothecin  
conjugates advanced to phase III and phase I clinical trial, respectively. [36-37]  Deming et 
al. elegantly demonstrate the controlled synthesis and self-assemble of the amphiphilic 
diblock copolymers, which could find various applications for tissue engineering and 
drug delivery.[27, 38-41] These studies revealed that polypeptides-based biomaterials have 
great potential for a number of biomedical applications. 
 
One unique advantage of utilizing polypeptides as biomaterials is the secondary 
structure of the polypeptides, which is inaccessible in other synthetic polymeric 
materials.[42-44] Synthetic polypeptides can self-organize into highly ordered secondary 
structures such as α-helix and β-sheets in solution phase or in solid state, same as those 
typically observed in proteins or peptides. These secondary structures regulate the unique 
properties and functions in vitro or in vivo, facilitating their biomedical applications.    
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1.2 Scope and Organization 
My Ph.D. research focused on the development of the controlled ROP of NCAs 
for the synthesis of highly uniformed polypeptides-based materials with predictable MW, 
narrow MWD and controlled structures and architectures.  I also explored the properties 
and applications of the polypeptides in gene delivery.  
 
The organization of my thesis is briefly described below (Figure 1.1). I will focus 
on the development of hexamethyldisilazane (HMDS) mediated controlled ROP of NCAs 
and its mechanistic study in Chapter 2. In Chapter 3, I will describe how I successfully 
extended the controlled polymerization from HMDS to various N-TMS amines and 
utilized the technique to facilely functionalize the C-terminus of polypeptides. A new 
one-pot strategy by incorporating ROP of NCA and ROMP for the synthesis of 
polypeptide-bearing brush-like polymers will be described in Chapter 4.  Development of 
novel functional NCA monomer and its controlled polymerization will be presented in 
Chapter 5. In Chapter 6, I will discuss the ionic polypeptides with unusual helical 
stability. Finally, the polypeptides-based gene delivery will be shown in Chapter 7.  
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polypeptides
 
Scheme 1.1   ROP of NCA for the preparation of polypeptides  
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Scheme 1.2    “Amine” (a, upper) and “Activated Monomer” (b, lower) mechanisms of 
conventional NCA polymerization. (Copy from Ref. # 19)  
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Scheme 1.3    Structures of BpyNi(COD) and (PMe3)4Co catalysts 
 
N
H H
O O
HN
N
H H
O O
X Y
O
N
H
R
polynorbornene-
g-polypeptide
n
One-pot synthesis of
Brush-like Polypeptides
PVBLG-8 PEI PVBDLG-8
 
Figure 1.1    Summary of the contents of my dissertation 
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CHAPTER 2  
CONTROLLED POLYMERIZATION OF NCA USING 
HEXAMETHYLDISILAZANE 
 
2.1 Introduction 
Polypeptides are a class of important biomaterials that are extensively utilized in 
drug delivery,[1] tissue engineering,[2] sensing[3] and catalysis.[4]  They are usually 
prepared through amine initiated ring-opening polymerization (ROP) of α-amino acid-N-
carboxyanhydrides (NCAs). Although large-scale, high molecular weight (MW) 
polypeptides can be readily synthesized using this method, the resulting polypeptides 
typically have uncontrollable MWs and broad MW distributions (MWD).[5]  In the past 
several decades, tremendous efforts have been devoted to the development of initiators 
for controlled NCA polymerization,[5] resulting in exciting achievements through the 
modification of conventional amine initiators[6] or polymerization conditions,[7] or by 
developing zero-valent transition metal catalysts.[8-9]  
 
Inspired by the success achieved in the ROP of lactide (LA) utilizing 
organocatalysts, we sought to develop simple systems for organocatalyst-mediated NCA 
polymerization.[10] One of the major reasons for the uncontrolled NCA polymerization is 
unwanted side reactions such as chain transfer and chain termination caused by the highly 
reactive ring-opened NCA. To eliminate those side reactions, we reasoned that a 
regulating group that could modulate the reactivity of the chain propagation center during 
the polymerization would be required in order to control the polymerization. With this in 
mind, I screened organocatalysts that could open the NCA ring and discovered that 
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hexamethyldisilazane (HMDS) resulted in a surprisingly controlled NCA polymerization 
(Scheme 2.1). I was intrigued by the excellent control over polymerization and went on 
and performed a full-scale investigation.  I successfully establish a new method of 
controlling NCA ROP and identified trimethylsilyl carbamate (TMS-CBM) as an 
unusual, unprecedented group mediating the chain propagation.   
 
Scheme 2.1  HMDS mediated NCA polymerization 
 
 
 
 
 
 
 
2.2 Materials and Methods 
2.2.1 General 
Anhydrous dimethylformamide (DMF) was dried by two 4Å molecular sieves 
columns and stored with molecular sieves in a glove box.  Anhydrous THF, anhydrous 
hexane, trimethylsilyl dimethylcarbamate (TMSDC) and 1,1,1,3,3,3-
hexamethyldisilazane (HMDS) were purchased from Sigma (St. Louis, Mo) and used as 
received. Methylene chloride was purchased from J. T. Baker (Phillipsburg, NJ).  
Anhydrous DMSO-d6 was prepared by treating regular DMSO-d6 (Cambridge Isotope 
Laboratories, Andover, MA) with calcium hydride at 70 oC under N2 overnight followed 
by distillation under reduced pressure. H-Glu(OBn)-OH and H-Lys(Z)-OH were 
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purchased from Chem-Impex International (Des Plaines, IL) and used as received.  NMR 
spectra were recorded on a Varian 400 MHz or on a Varian VXR 500 MHz spectrometer. 
Tandem gel permeation chromatography (GPC) was performed on a system equipped 
with an isocratic pump (Model 1100, Agilent Technology, Santa Clara, CA), a DAWN 
HELEOS 18 angle MALLS light scattering detector (Wyatt Technology, Santa Barbara, 
CA) and an Optilab rEX refractive index detector (Wyatt Technology, Santa Barbara, 
CA). The detection wavelength of HELEOS was 658 nm.  Separations were effected by 
500 Å, 103 Å and 104 Å Phenogel columns (5 µm, 300 × 7.8 mm, Phenomenex, Torrance, 
CA) using DMF containing 0.1 M LiBr as the mobile phase at 60 °C. Infrared spectra 
were recorded on a Perkin Elmer 1600 FT-IR spectrophotometer calibrated with 
polystyrene film. Low resolution FAB-MS was collected on a Micromass 70-VSE mass 
spectrometer. High resolution FAB-MS was collected on a Waters 70-SE-4F mass 
spectrometer. 
 
2.2.2 Synthesis and polymerization of NCA monomers 
2.2.2.1 Synthesis of (S)-γ-benzyl-glutamate-N-carboxyanhydride (Glu-NCA)    A 250 mL 
round bottom schlenk flask charged with H-Glu(OBn)-OH (2.37 g, 10 mmol), 
triphosgene (1.49 g, 5 mmol) and a stir bar was vacuumed for 2 hrs at room temperature.  
Anhydrous THF (100 mL) was added under nitrogen. The mixture was stirred at 40 oC 
for 2 hrs. The suspension gradually turned clear, which indicats the completion of the 
reaction. The solvent was removed under vacuum to give crude Glu-NCA. The crude 
NCA was purified by recrystallization in a glove box four times using a mixture of 
hexane and THF resulting in Glu-NCA in crystalline form (2.10 g, 83%).  1H NMR 
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(DMSO-d6, 500 MHz): δ 9.11 (s, 1H, NH), 7.3-7.4 (m, 5H, ArH), 5.10 (s, 2H, C6H5CH2), 
4.47 (dd, 1H, α-CH), 2.52 (t, 2H, β-CH2), 2.05 (m, 1H, γ-CH), 1.92 (m, 1H, γ-CH). 13C 
NMR (DMSO-d6, 500 MHz): δ 172.4, 172.0, 152.6, 136.7, 129.1, 128.8, 128.7, 66.4, 
57.0, 29.8, 27.1. The 13C NMR, 1H NMR and FT-IR spectra of this material are identical 
to data found for the authentic sample of Glu-NCA.   
 
2.2.2.2 Synthesis of (S)-ε-carbobenzoxy-lysine-N-carboxyanhydride (Lys-NCA)  The Lys-
NCA was synthesized following the same procedure as the synthesis of the Glu-NCA 
(78%).  1H NMR (DMSO-d6, 500MHz): δ 9.08 (s, 1H, ring NH), 7.30-7.36 (m, 5H, ArH), 
7.26-7.28 (m, 1H, side chain NH) 5.01 (s, 2H, C6H5CH2), 4.40 (dd, 1H, α-CH), 2.96 (m, 
2H, N-CH2-), 1.63-1.71 (m, 2H, β-CH2), 1.28-1.41 (m, 4H, -NHCH2CH2CH2CH2-). 13C 
NMR (DMSO-d6, 500MHz): δ 171.8, 156.1, 152.0, 137.3, 128.4, 127.8, 65.1, 57.0, 41.3, 
31.1. 30.6, 28.7 
 
2.2.2.3 General procedure for the polymerization of Glu-NCA  In a glove box Glu-
NCA (26 mg, 0.1 mmol) was dissolved in DMF (0.5 mL). The Glu-NCA solution was 
added to a HMDS/DMF solution (10 µL, 0.1 mmol/mL). The reaction mixture was stirred 
for 15 hrs at room temperature. The real-time concentration of NCA was quantified by 
measuring the intensity of NCA’s anhydride peak at 1790 cm-1 by FT-IR. The conversion 
of NCA was determined by comparing the NCA concentration in the polymerization 
solution with the NCA concentration at t = 0. After diluting the concentration of PBLG to 
10 mg/mL using DMF (containing 0.1 M LiBr), the solution was analyzed by GPC to 
measure the molecular weight of PBLG.  The remaining PBLG was precipitated with 8 
14 
 
mL methanol. The obtained PBLG was sonicated for 5 minutes and centrifuged to 
remove the solvent. After the sonication-centrifugation procedure was repeated two more 
times, PBLG was collected and dried under vacuum (17 mg, 78%). Polymerizations of 
Glu-NCA initiated with diethylamine (DEA), triazabicyclodecene (TBD) and 
trimethylsilyl dimethylcarbamate (TMSDC), and characterization of the resulting PBLGs 
were similarly carried out.  
 
2.2.2.4  General procedure for the synthesis of block polypeptides   In a dry box, Lys-
NCA (30 mg, 0.1 mmol) was dissolved in DMF (0.5 mL). The solution was then added to 
a HMDS solution in DMF (10 µL, 0.1 mmol/mL). The reaction mixture was stirred for 42 
hrs.  After the Lys-NCA was completely consumed (monitored by FT-IR), Glu-NCA (26 
mg, 0.1 mmol) in DMF (0.5 mL) was added to the mixture to make the second black. The 
polymerization of Glu-NCA was complete after 24 hrs. The molecular weights of first 
block (PZLL) and the block-copolymer (PZLL-b-PBLG) were analyzed by GPC. 
 
2.2.3  Mechanistic study of HMDS mediated NCA polymerization 
2.2.3.1 FT-IR analysis of equal molar mixture of Glu-NCA and HMDS   Glu-NCA (26 
mg, 0.1 mmol) in anhydrous CH2Cl2 (600 µL) was added dropwise to an anhydrous 
CH2Cl2 solution containing HMDS (16 mg, 0.1 mmol). The solution was allowed to stir 
in glove box at room temperature overnight. The FT-IR spectrum was collected on a KBr 
salt plate. 
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2.2.3.2 13C NMR analysis of equal molar mixture of Glu-NCA and HMDS   An anhydrous 
DMSO-d6 solution (600 µL) containing Glu-NCA (26 mg, 0.1 mmol) was added 
dropwise to an anhydrous DMSO-d6 solution (400 µL) containing HMDS (16 mg, 0.1 
mmol). The solution was allowed to stir in a glove box at room temperature for 16 hrs. 
The reaction solution was transferred to a NMR tube in glove box. The NMR tube was 
capped, sealed with parafilm to avoid exposure to moisture, and analyzed on a Varian 
VXR-500 MHz spectrometer.   
 
2.2.3.3 High-Resolution FAB-MS analysis of equal molar mixture of Glu-NCA and 
HMDS An anhydrous DMSO-d6 solution (600 µL) containing Glu-NCA (26 mg, 0.1 
mmol) was added dropwise to an anhydrous DMSO-d6 solution (400 µL) containing 
HMDS (16 mg, 0.1 mmol). The solution was allowed to stir in a glove box at room 
temperature for 16 hrs. The reaction solution was analyzed on a Waters 70-SE-4F mass 
spectrometer for high-resolution FAB-MS. 
 
2.2.3.4  FAB-MS study of 5:1 ratio of Lys-NCA and HMDS  Lys-NCA (30 mg, 0.1 mmol) 
was dissolved in anhydrous DMF (500 µL).  The solution was added dropwise to a DMF 
solution (200 µL) containing HMDS (3.2 mg, 0.02 mmol). The reaction mixture was 
stirred overnight at room temperature and then analyzed with FAB-MS under anhydrous 
condition. 
 
2.3 Results and Discussion 
2.3.1 HMDS mediated NCA polymerization 
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As an active silylation reagent, hexamethyldisilazane (HMDS) is widely used in 
organic synthesis.[11-12] In a screen of amine initiators for the polymerization of γ-benzyl-
L-glutamate NCA (Glu-NCA), we found HMDS gave remarkable control of 
polymerizations and led to formation of PBLG with expected MWs (Figure 2.1a).  The 
obtained PBLG MW (Mn = 2.18 × 104 g/mol) at M/I of 100, for instance, agreed perfectly 
with the expected PBLG MW (Mn = 2.19 × 104 g/mol) in this HMDS mediated 
polymerization. Polymerization initiated by HMDS completed within 12-48 hrs 
(depending on the M/I ratios) at room temperature with quantitative monomer 
conversions and narrow MWDs (1.26-1.10). The MWs of PBLG had linear correlation 
with the conversions of Glu-NCA and agreed well with the expected MWs (Figure 2.1b), 
demonstrating that PBLG chains propagated through living chain ends in the HMDS 
mediated NCA polymerizations. Block co-polypeptides, such as poly(γ-benzyl-L-
glutamate)-block-poly(ε-Cbz-L-lysine) (PBLG-b-PZLL), with expected MWs and narrow 
MWDs also can be prepared readily.  
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Figure 2.1  HMDS mediated Glu-NCA polymerization. Plot of Mn, MWD versus NCA/HMDS 
ratios (a, left panel) and plot of Mn, MWD versus NCA conversion at M/I of 100/1 (b, right panel). 
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2.3.2    Mechanistic study  
Though numerous amines have been explored for NCA polymerizations, none of 
them gives controlled polymerizations close to what we observed with HMDS. The well-
controlled polymerizations observed with HMDS suggest that the initiation and chain 
propagation mechanism differs from either the “amine” or the “activated monomer” 
mechanism.  We originally ascribed the excellent control to the higher basicity of HMDS 
(pKa =14)[13] as compared with other aliphatic amines previously studied (pKa =10-
12).[14] However, polymerizations of Glu-NCA initiated by strong bases such as alky 
oxides or triazabicyclodecene (TBD), a very strong secondary amine base with a pKa 
around 26,[15]  did not show any control of PBLG MWs (data not shown). Thus, the 
unusual capability of controlling NCA polymerization by HMDS was likely related to its 
TMS group.  
 
As a secondary amine, HMDS can function as either a nucleophile to open the 
NCA ring at CO-5 or as a base to deprotonate the NH-3.[14] Previous studies showed that 
secondary amines with bulky alkyl groups such as diisopropylamine exclusively 
deprotonated NCAs.[16] Therefore, it is unlikely that HMDS, a secondary amine 
containing two bulky TMS groups, to nucleophilically attack the CO-5 of Glu-NCA 
directly. On the other hand, deprotonation of NCAs by HMDS should result in the 
formation of N-TMS NCAs that could undergo rapid rearrangement to form α-
isocyanatocarboxylic acid TMS esters.[14]  However, no isocyanate peak (around 2270 
cm-1) was observed when the mixture of Glu-NCA/HMDS (1/1) was analyzed by FT-IR.  
Thus, it is likely that a TMS group transferred to CO-3 from HMDS as shown in Figure 
2.2 and formed intermediate 2.  The Si-N-Si band of HMDS at 932 cm-1 in FT-IR 
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disappeared after mixing equal molar Glu-NCA and HMDS (Figure 2.3), which clearly 
indicated the cleavage of N-Si bond.  Therefore, it is likely instead of forming isocyanate, 
the rapid ring-opening by the in situ generated TMS-amine (Figure 2.2) led to formation 
of a TMS carbamate 3 (TMS-CBM).  
 
To confirm the formation of 3, I mixed equal molar Glu-NCA and HMDS in 
DMSO-d6 and then analyzed the mixture using 13C NMR and FAB-MS. The anhydride 
carbon peak of Glu-NCA at 152.0 ppm disappeared, and a new peak at 156.4 ppm 
appeared (Figure 2.4).  The new peak corresponds to the formation of a carbamate bond.  
Interestingly, when the FAB-MS study was carried out with minimum exposure to air, 3 
and its decomposed derivatives were detected (Figure 2.5). These experiments 
demonstrated that 3 contained an active, moisture-sensitive group.  Using high-resolution 
FAB-MS, we determined the molecular formula of 3 to be C19H33O5N2Si2 (Figure 2.6).  
The MS analysis of a mixture of Lys-NCA and HMDS (5:1 molar ratio) showed peaks 
(468 Da, 730 Da, 992 Da, 1254 Da, 1516 Da, 1801 Da and 2040 Da) corresponding to 
oligolysine species with identical TMS carbamate terminal groups as the Glu species 3 
(Figure 2.7) . Degradation species agreeing with the loss of TMS and carbon dioxide 
were also successfully observed.  These experiments indicated that polypeptide chains 
may propagate through the migration of TMS end groups to the incoming monomers 
(Figure 2.2).  This reaction resembles, to some extent, the group-transfer polymerizations 
(GTPs) of acrylic monomers mediated by similar organosilicon compounds.[17] It is 
unclear whether the TMS is transferred to the incoming monomer through an anionic 
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process as in GTP of acrylic monomers[18] or a concerted process tentatively illustrated in 
Figure 2.2. 
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Figure 2.2   Proposed mechanism of HMDS mediated NCA polymerization 
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Figure 2.3   FT-IR spectrum (selected) of 1:1 molar ratio of Glu-NCA/HMDS mixture. The 
solution was prepared in dry DCM and spectrum was measured 10 min after mixing. 
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Figure 2.4   13C NMR spectrum (selected) of 1:1 molar ratio of Glu-NCA/HMDS mixture. The 
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Figure 2.5    FAB MS spectrum of 1:1 molar ratio of Glu-NCA/HMDS mixture. The solution 
was prepared in dry DMSO-d6 and sealed in the glove box before measuring.  
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Formula Calculated Mass Error Unsaturation
C32H25O 425.19055 2.1 20.5
C25H29O6 425.19642 -3.8 21.0
C30H23N3 425.18920 3.4 21.0
C23H27O5N3 425.19507 -2.5 12.0
C28H29O2Si 425.19369 -1.1 15.5
C23H29O4N2Si 425.18967 2.9 11.5
C26H27ON3Si 425.19235 0.2 16.0
C24H33O3Si2 425.19684 -4.2 10.5
C19H33O5N2Si2 425.19281 -0.2 6.5
C22H31O2N3Si3 425.19549 -2.9 11.0
Selected isotopes: CHO0-6N0-4Si0-2
Measured Mass 425.19260
Error Limit: 5 mmu
Unsaturation Limits: -0.5 to 30
NHTMS
O
HN
O
O
O
O
TMS
C19H33O5N2Si2 =
 
Figure 2.6    High resolution FAB MS analysis the peak m/z = 425.19260. Sample was prepared 
in glove box by mixing 1:1 molar ratio of Glu-NCA and HMDS in dry DMF. The solution sealed 
in the glove box before measuring.  
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Figure 2.7    FAB MS spectrum of 5:1 molar ratio of Lys-NCA/HMDS mixture. The solution 
was prepared in dry DMF and sealed in the glove box before measuring.  
 
 
 
2.4 Conclusions 
 
In conclusion, we discovered an unusual TMS-CBM propagating group that can 
control the living polymerization of NCAs. This organosilicon reagent, HMDS mediated 
NCA polymerization offers a metal-free strategy for the convenient synthesis of homo- or 
block-polypeptides with predictable MWs and narrow MWDs. 
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CHAPTER 3  
CONTROLLED POLYMERIZATION OF NCA: N-TMS AMINES 
3.1 Introduction 
To prepare polypeptides for applications, it is important to control not only the 
molecular weights (MWs) but also the end groupsof polypeptides[1-3].  Unfortunately, this 
is impossible when hexamethyldisilazane (HMDS) is used as the initiator as the polymers 
are always terminated with N-TMS amide.  However, the mechanistic study of HMDS-
mediated NCA polymerization indicates that when a N-TMS amine is used as the 
initiator, cleavage of the Si-N bond will generate an amine and a TMS group (Scheme 
3.1b) that will subsequently form the corresponding amide at the C-terminus and TMS-
CBM at the N-terminus after NCA ring opening (Scheme 3.1b). Thus, chain propagation 
should proceed in the same manner as HMDS-mediated polymerization when other N-
TMS amines are used (Scheme 3.1a).  Because a large variety of N-TMS amines are 
commercial available, this method should allow for facile functionalization at the C-end 
of polypeptides.  
 
Scheme 3.1   
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3.2 Materials and Methods 
3.2.1 General 
Dimethylformamide (DMF) was dried by 4Å molecular sieves (MS) columns 
prior to use. Anhydrous THF, anhydrous hexane, N-trimethylsilyl (TMS) allylamine (1-
TMS), N-TMS morpholine (3-TMS), Chlorotrimethylsillane (redistilled), 
hexamethyldisilazane, 5-norbornene-2,3-dicarboxylic anhydride, propargylamine, N-
TMS tert-butylamine, N,O-bis(trimethylsilyl) acetamide (BSA), ethylenediamine and 
triphosgene were purchased from Sigma (St. Louis, Mo) and used as received. 
Anhydrous triethylamine (TEA) was prepared by treating regular TEA (Sigma, St. Louis, 
Mo) with calcium hydride overnight under nitrogen at 40 oC followed by distillation 
under nitrogen. Anhydrous DMSO-d6 was prepared by treating regular DMSO-d6 
(Cambridge Isotope Laboratories, Andover, MA) with calcium hydride overnight under 
nitrogen at 70oC followed by distillation under reduced pressure. Anhydrous CDCl3 was 
prepared by treating regular CDCl3 (Sigma, St. Louis, Mo) with P2O5 overnight followed 
by distillation under nitrogen. Anhydrous benzylamine (2) and allylamine (1) were 
prepared by treating regular reagents (Sigma, St. Louis, Mo) overnight with KOH 
followed by distillation under reduced pressure and under nitrogen, respectively. 
Anhydrous propargylamine (4) was obtained by treating regular propargylamine (Sigma, 
St. Louis, Mo) with 4Å molecular sieves.  All purified anhydrous reagents were stored in 
the presence of 4Å molecular sieves. H-Glu(OBn)-OH and H-Lys(Z)-OH were purchased 
from Chem-Impex International (Des Plaines, IL) and used as received.  Preparation and 
recrystallization of Glu-NCA and Lys-NCA were performed by following published 
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procedures.[4] NMR spectra were recorded on a Varian UI500NB MHz or on a VXR-500 
MHz spectrometer.  Tandem gel permeation chromatography (GPC) was performed on a 
system equipped with an isocratic pump (Model 1100, Agilent Technology, Santa Clara, 
CA), a DAWN HELEOS 18 angle MALLS light scattering detector (Wyatt Technology, 
Santa Barbara, CA) and an Optilab rEX refractive index detector (Wyatt Technology, 
Santa Barbara, CA). The detection wavelength of HELEOS was set at 658 nm.  
Separations were effected by 50Å, 500Å, 103Å and 104Å Phenogel columns (5 µm, 300 × 
7.8 mm, Phenomenex, Torrance, CA) using DMF containing 0.1 M LiBr as mobile phase 
at 60°C. Low resolution Electrospray Ionization Mass spectrometry (ESI-MS) was 
collected on a Waters Quattro II Mass Spectrometer. Matrix Assisted Laser 
Desorption/Ionization-Time Of Flight mass spectrometer (MALDI MS) spectra were 
collected on a Applied Biosystems Voyager-DE STR system. 
 
3.2.2 Synthesis of Various N-TMS amines 
3.2.2.1  Synthesis of N-TMS benzylamine (2-TMS)   Anhydrous benzylamine (2.14 g, 20 
mmol) and HMDS (1.81 g, 11 mmol) were mixed in a 100 mL round flask under nitrogen.  
One drop of concentrated H2SO4 was added to the mixture followed by refluxing for 3 
hours. N-TMS benzylamine (2-TMS) was distilled out under reduced pressure as 
colorless oil (2.5 g, 70%).  1H NMR (CDCl3, 500 MHz): δ 7.40-7.30 (m, 5H, ArH), 4.02 
(s, 2H, C6H5CH2), 0.91 (broad, 1H, NH), 0.10 (9H, Si(CH3)3). 13C NMR (CDCl3, 500 
MHz): δ 144.3, 128.2, 126.9, 126.3, 45.9, 0.00. 
3.2.2.2  Synthesis of N-TMS propargylamine (4-TMS)  An oven dried 50 mL two 
neck round bottle was equipped with a stir bar. One neck of the round bottle was stopped 
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by a rubber septum and the other one was stopped by an adapter with a stopcock. The 
bottle was further dried under vacuum and then charged with nitrogen. Propargylamine 
(Pre-dried by 4Å molecular sieves for 6 hr) (4, 110 mg, 2.0 mmol) was added into the 
bottle by syringe. Ice bath was added to the bottle and the liquid was cooled to 0 oC. N,O-
bis(trimethylsilyl) acetamide (BSA, 0. 5 Ml, 2.0 mmol) was added by syringe dropwise 
within 10 min. the solution was stirred under ice bath for another 30 min. flushing with 
the nitrogen, the rubber septum was removed and the oven dried distillation kit was 
equipped very rapidly. The same 2-neck round bottle as the reaction vessel was used as 
the receiving bottle. Vacuum was added from one of the necks of the receiving bottle and 
the receiving bottle was placed in a liquid nitrogen dewar flask. The product was trapped 
in the receiving bottle by applying medium vacuum very carefully. After distillation, 
nitrogen was flushed into the flask from the receiving bottle, condenser was removed and 
the receiving bottle was sealed by a glass stopper very rapidly. The product was then 
pumping into the glove box immediately. 1H NMR (DMSO-d6, 500 MHz): δ 3.39 (dd, 
2H, CH2, J1 = 2.5 Hz, J2 = 8.0 Hz), 2.95 (t, 1H, HC, J = 2.5 Hz), 1.86 (broad, 1H, NH), 
0.02 (s, 9H, Si(CH3)3). 13C NMR (CDCl3, 500 MHz): δ 86.9, 72.3, 31.0, 0.8. Elemental 
analysis: % C 56.63, % H 10.30, % N 11.01; found % C 54.98, % H 10.47, % N 10.50. 
 
   
                                   5         5-TMS 
Scheme 3.2 
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3.2.2.3  Synthesis of N-(N-trimethylsilylaminoethylene)-5-norbornene-endo-2,3-
dicarboximide (5-TMS)  (Scheme 3.2) 
Step 1:  5-norbornene-endo-2,3-dicarboxylic anhydride (1.57 g, 10 mmol) was 
added dropwise to a flask containing vigorously stirred, excess ethylenediamine (30 mL, 
0.45 mol) at room temperature. The mixture was heated up to 120 oC for 12 hrs.  After 
the reaction solution was cooled to room temperature, DI water (30 mL) and ethyl acetate 
(30 mL) were added. 5 was extracted into the organic (ethyl acetate) phase.  The aqueous 
phase was further extracted with ethyl acetate (2 × 20 mL).  The combined organic phase 
was washed with DI water (10 mL) to remove remaining ethylenediamine.  The solvent 
was then removed under reduced vacuum.  5 (1.4 g, 70%) in white solid form was 
obtained.  1H NMR (CDCl3, 500 MHz): δ 6.12 (s, 2H, Ha), 3.42-3.40 (m, 4H, Hb and Hf), 
3.28 (s, 2H, He), 2.76-2.74 (m, 2H, Hg), 1.75 (d, 1H, Hd, J = 9.0 Hz), 1.54 (d, 1H, Hc, J 
= 9.0 Hz), 1.02 (broad, 2H, NH2). 13C NMR (CDCl3, 500 MHz): δ 178.2, 134.8, 52.5, 
46.0, 45.2, 42.0, 40.4. 
Step 2:  In a glove box, 5 (206 mg, 1.0 mmol) was dissolved in anhydrous THF (5 
mL). This solution was mixed with an ether solution (2 mL) of TEA (120 mg, 1.2 mmol).  
After TMSCl (120 mg, 1.1 mmol) was added, the mixture was stirred overnight at room 
temperature under argon. The precipitate was then removed by filtration.  The solvent of 
the filtrate was removed under reduced pressure to give the crude 5-TMS (250 mg, 92%). 
Pure 5-TMS in needle crystalline form was obtained by recrystallization of the crude 
product in ether at −30 oC and then used for polymerization. 1H NMR (CDCl3, 500 MHz): 
δ 6.09 (s, 2H, Ha), 3.38 (s, 2H, Hb), 3.32 (t, 2H, Hf, J = 7 Hz), 3.25 (s, 2H, He), 2.76-
2.72 (m, 2H, Hg), 1.73 (d, 1H, Hd, J = 8.5 Hz), 1.54 (d, 1H, Hc, J = 8.5 Hz), 0.43 (broad, 
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1H, NH), 0.01 (9H, Si(CH3)3). 13C NMR (CDCl3, 500 MHz): δ 178.1, 134.7, 52.4, 46.0, 
45.1, 42.1, 39.8, 0.17. Elemental analysis: % C 60.39, % H 7.96, % N 10.06; found % C 
59.94, % H 7.40, % N 9.95. m.p. 69-70 oC. 
 
3.2.2.4 N-TMS mPEG2000-amine (6-TMS)  
6-TMS was prepared and purified using the same method as for the preparation of 
5-TMS. 
 
3.2.3 N-TMS amines initiated Polymerization of NCA and mechanistic study   
3.2.3.1 General Procedure for the polymerization of Glu-NCA  In a glove box, Glu-
NCA (26 mg, 0.1 mmol) was dissolved in DMF (0.5 mL). The Glu-NCA solution was 
added to a DMF solution of 1-TMS (10 µL, 0.1 mmol/mL). The reaction mixture was 
stirred for 15 hrs at room temperature. The real-time concentration of NCA was 
quantified by measuring the intensity of NCA’s anhydride peak at 1789 cm-1 by FT-IR.  
The conversion of NCA was determined by comparing the NCA concentration in the 
polymerization solution versus the initial NCA concentration. An aliquot of the 
polymerization solution was diluted to 10 mg PBLG/mL using DMF (containing 0.1 M 
LiBr), and then analyzed by GPC. The remaining PBLG was precipitated with 8 mL 
methanol. The obtained PBLG was sonicated for 5 minutes in ether and centrifuged to 
remove the solvent.  After the sonication-centrifugation procedure was repeated two more 
times, PBLG was collected and dried under vacuum.  
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3.2.3.2 General Procedure for the block polypeptides synthesis   In a dry box, Lys-NCA 
(30 mg, 0.1 mmol) was dissolved in DMF (0.5 mL). The Lys-NCA solution was then 
added to a DMF solution containing 1-TMS (10 µL, 0.1 mmol/mL). The reaction mixture 
was stirred for 24 hrs at room temperature. After the Lys-NCA was completely consumed 
(monitored by checking the NCA anhydride band at 1790 cm-1 using FT-IR), Glu-NCA 
(26 mg, 0.12 mmol) in DMF (0.5 mL) was added to the mixture to make the second block.  
The polymerization of Glu-NCA was complete after 24 hrs. The molecular weights of 
first block (PZLL) and the block-copolymer PZLL-b-PBLG were analyzed by GPC.  
 
3.2.3.3 Evaluation of equal molar mixture of 1-TMS and Lys-NCA with ESI-MS  
 
 Lys-
NCA (30 mg, 0.1 mmol) was dissolved in anhydrous DMF (500 µL), and then added 
dropwise to a DMF solution (100 µL) containing 1-TMS (14 mg, 0.1 mmol).  The 
reaction mixture was stirred overnight at room temperature and analyzed with ESI-MS 
under anhydrous conditions.
 
 
3.2.3.4  Evaluation of equal molar mixture of N-TMS tert-butylamine and Glu-NCA with 
13C-NMR       In a glove box, an anhydrous DMSO-d6 solution (600 µL) containing Glu-
NCA (26 mg, 0.1 mmol) was added dropwise to an anhydrous DMSO-d6 solution (400 
µL) containing N-TMS tert-butylamine (15 mg, 0.1 mmol).  The solution was stirred in 
the glove box at room temperature for 30 minutes. The reaction solution was transferred 
to a NMR tube in the glove box.  The NMR tube was capped, sealed with parafilm to 
avoid exposure to moisture, and analyzed on a Varian VXR-500 MHz spectrometer.   
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3.3           Results and Discussion 
3.3.1     1-TMS mediated controlled polymerization of Glu-NCA  
To demonstrate the concept of using N-TMS amines for the controlled NCA 
polymerization, N-TMS allylamine (1-TMS) was utilized as the initiator for the 
polymerization of Glu-NCA. As shown in Figure 3.1a, 1-TMS showed remarkable 
control of polymerization and gave PBLG with expected MWs and narrow MWDs in a 
broad range of monomer/initiator (M/I) ratios (M/I = 20-500). The obtained MWs of 
PBLG at M/I of 20 and 500 were 4.6 × 103 g/mol and 9.58 × 104 g/mol, respectively, 
both of which were nearly identical to the expected MWs (4.4× 103 g/mol and 1.09 × 105 
g/mol, respectively). All polymerizations were finished within 12-48 hours at room 
temperature under atmospheric pressure, in contrast to a few recently reported controlled 
polymerizations that require either reduced temperature[5] or vacuum.[6] The MWs of 
PBLG showed linear correlation with the conversions of Glu-NCA and agreed well with 
the expected MWs (Figure 3.1b), demonstrating that PBLG chains were propagated 
through living chain ends. .  1-TMS also showed remarkable control of polymerizations 
of ε-Cbz-L-lysine NCA (Lys-NCA), and resulted in poly(ε-Cbz-L-lysine) (PZLL) with 
expected MWs and very narrow MWDs (Figure 3.2). Block copolypeptides, such as 
PBLG-b-PZLL can also be readily prepared with anticipated MWs and narrow MWDs 
via sequential addition of Lys- and Glu-NCA (Table 3.1). 
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Figure 3.1 (a) MWs and MWDs of PBLGs from ROP of Glu-NCA initiated by 1-TMS at 
variable M/I ratios. Black curve is the theoretical line and the red dots are experimental results. (b) 
MWs of PBLG versus conversion of Glu-NCA for polymerization initiated by 1-TMS (M/I =100). 
Black curve is the theoretical line and the red dots are experimental results. (c) MALDI MS 
spectra of PBLGs initiated by 1-TMS (blue) and by allylamine (red) (M/I = 20); the numbers on 
MALDI MS denote the degree of polymerization (n). (d) GPC curve of PBLG prepared by 1-
TMS (blue) and by allylamine (red) (M/I = 50). 
 
I next compared polypeptides obtained from allylamine and 1-TMS initiated 
polymerization. PBLG resulted from allylamine-initiated Glu-NCA polymerization at 
M/I of 20 had a broad MWD (Mw/Mn=1.52) according to MALDI MS analysis (red, 
Figure 3.1c). In contrast, PBLG resulted from 1-TMS polymerization had a much narrow 
MWD (Mw/Mn=1.17).  Its MALDI MS spectrum showed a Poisson distribution centered 
at the exact theoretical MW with the anticipated allyl amide end group (MW = allylamine 
+ (Glu)20) (blue, Figure 3.1c),  which was dramatically different from that of the PBLG 
derived from  allylamine (blue vs. red).  The bimodal GPC curve of the PBLG derived 
from 1 (red, Figure 3.1d) versus the sharp, monomodal curve of the PBLG derived from 
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1-TMS (blue, Figure 3.1d) further demonstrated substantially improved polymerization 
control with the subtle modification of the amine initiator.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2  1-TMS initiated Lys-NCA polymerization in DMF. The black line is the theoretical 
line, the pink dots are experimental results and the green dots are PDI values. 
 
 
 
Table 3.1  1-TMS initiated copolymerization for the synthesis of block co-polypeptides  
 
entry NCA (NCA/initiator 
ratio)a
M n expected 
(g/mol)b
M n obtained 
(g/mol)b M w/M n
conv. of NCA 
(%)c
1 Lys(50)/Glu(60) 13,100/26,240 14,100/31,300 1.07/1.04 >99/>99
2 Lys(100)/Glu(120) 26,200/52,480 24,800/52,800 1.06/1.07 >99/>99
 
a Synthesis of (PBLG-b-PZLL) block copolypeptide via the sequential addition of Lys-NCA and 
Glu-NCA to a 1-TMS solution, and determination of Mn and Mw/Mn (MWD) of PZLL/PBLG-b-
PZLL. bMn of first block/Mn of copolymer. cdetermined by FT-IR by measuring the intensity of 
NCA anhydride band at 1790 cm-1. 
 
 
3.3.2     Mechanistic study of 1-TMS mediated NCA polymerization  
To confirm the formation of TMS-CBM during 1-TMS mediated NCA 
polymerization, I mixed equal molar Lys-NCA and 1-TMS and analyzed the mixture 
using ESI-MS (Figure 3.3).  1-Lys-TMS-CBM (iii, m/z 436.5) was successfully 
identified to be the dominating component in the mixture, thus demonstrating that 1-TMS 
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follows a similar polymerization mechanism as HMDS.  When the MS experiment was 
performed under anhydrous condition, both iii and its decomposed derivatives ii and i 
were detected (Figure 3.3). However, when the reaction mixture was exposed to air or if 
D2O was added, only i was detected (data not shown).  These observations were in line 
with the expected moisture-sensitivity of TMS-CBM.[7] Formation of TMS-CBM during 
the initiation step was further confirmed by 13C NMR (Figure 3.4). 
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Figure 3.3 ESI-MS of equal molar mixture of 1-TMS and Lys-NCA  
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Figure 3.4 13C NMR spectra of Glu-NCA (i) and equal molar mixture of N-TMS tert-butylamine 
and Glu-NCA (ii). 
 
3.3.3    Various N-TMS amines mediated controlled polymerization of Glu-NCA  
To evaluate whether 1-TMS-mediated, controlled NCA polymerization could be 
extended to other N-TMS amines, I selected benzyl amine, morpholine, propargyl amine, 
N-(aminoethylene)-5-norbornene-endo-2,3-dicarboximide, and mPEG2000 amine to 
represent primary (2-TMS) and secondary amines (3-TMS), amines containing functional 
groups that could be used for further reactions such as for click chemistry (4-TMS)[8] and 
ring-opening metathesis polymerization (5-TMS),[9] and terminal amines of polymers (6-
TMS).[3]  As expected, all initiators gave excellent control of the MWs of PBLG.  At M/I 
of 100, the Mn’s were 2.35 × 104, 2.18 × 104, 2.19 × 104, 2.38 × 104, 2.85 × 104 g/mol for 
2-TMS−6-TMS, respectively, which agreed nearly perfectly with the expected MW 
(Table 3.2). Polymerizations of Glu- and Lys-NCAs with these initiators in a broad range 
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of M/I ratios all gave corresponding polypeptides with controlled MWs and narrow 
MWDs (Table 3.3). 
In a typical amine-initiated polymerization, the amine can function as both a 
nucleophile to attack the CO-5 of NCA to open the NCA ring (the so-called “amine 
mechanism”) and a base to deprotonate the NH-3 of NCA (the so-called “activated 
monomer mechanism”).[10-11] Thus, those complex mechanisms make it extremely 
difficult to achieve controlled NCA polymerization using conventional amine initiators.  
When N-TMS amine is used an initiator, polypeptide chain-transfer via the “activated 
monomer mechanism” is likely completely eliminated as TMS-CBM is unable to 
deprotonate the NH-3. Thus, chain propagation can only proceed through the ring 
opening at the CO-5 position, resembles to some extent, but is much faster than, the 
ammonium mediated NCA polymerization.[1, 12] 
Table 3.2 N-TMS Amines for Glu-NCA Polymerization (M/I =100)  
 
initiator 
expected
 M n 
(g/mol)
obtained M n 
(g/mol) M w/M n
conv.of 
NCA (%)
 21,900 23,500 1.26 >99
 21,900 21,800 1.21 >99
 21,900 21,900 1.18 >99
 22,000 23,800 1.17 >99
  23,900 28,500 1.1 >99
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Table 3.3 NCA Polymerization Initiated by N-TMS amines (2-TMS−5-TMS). Conversions of 
monomer were > 95% in all experiments.   
 
entry NCA (NCA/initiator) initiator
M n obtained 
(g/mol)
M n expected 
(g/mol) M w/M n
1 Glu (100) 2-TMS 23,500 21,900 1.27
2 Glu (300) 2-TMS 82,000 65,700 1.29
3 Glu (500) 2-TMS 107,000 109,500 1.29
4 Glu (50) 3-TMS 11,500 10,950 1.25
5 Glu (100) 3-TMS 21,800 21,900 1.21
6 Glu (200) 3-TMS 39,700 43,800 1.17
7 Glu (300) 3-TMS 59,100 65,700 1.19
8 Glu (50) 4-TMS 11,800 10,950 1.16
9 Glu (100) 4-TMS 21,900 21,900 1.18
10 Glu (200) 4-TMS 41,900 43,800 1.12
11 Glu (300) 4-TMS 65,700 65,700 1.21
12 Glu (500) 4-TMS 83,400 109,500 1.22
13 Lys (50) 5-TMS 13,300 13,100 1.09
14 Lys (100) 5-TMS 22,700 26,200 1.04
15 Lys (200) 5-TMS 41,200 52,400 1.05
 
 
 
 
 
3.4 Conclusions 
 
 
In conclusion, N-TMS amines give remarkably controlled NCA polymerizations 
that allow for facile functionalization of polypeptides at their C-ends.  Polymerizations 
initiated by N-TMS amines are fast, give quantitative monomer conversions and do not 
require excessive monomer purification.[6] This methodology should be useful for 
controlled synthesis of functional polypeptide, polypeptide macromonomers, and 
polypeptide copolymers.   
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CHAPTER 4  
ONE-POT SYNTHESIS OF POLYPEPTIDES-BEARING BRUSH-LIKE 
POLYMERS 
 
 
4.1 Introduction 
Preparing synthetic, brush-like polymers using controlled polymerization 
techniques, such as anionic, radical, ring-opening metathesis polymerization (ROMP), 
has attracted much attention in the past decade.[1] Brush-like polymers derived from these 
methods contain predominately flexible side-chain polymers, such as poly(methyl 
methacrylate), poly(styrene) and poly(ethylene glycol).[2-3] Incorporating polypeptide that 
have intrinsic secondary structures as the brush side chains could significantly expand the 
horizon of brush-like macromolecules and lead to formation of materials with 
unprecedented properties. However, reports on brush-like macromolecules bearing 
polypeptide as the brush side chains are scarce, most of which are focused on grafting 
oligo- or polypeptide to the backbone polymers through the so-called “grafting to” or 
“grafting through” strategy that has no control over the site of grafting.[4-9] There also 
have been reports of grafting polypeptides through polymerization of amino acid N-
carboxyanhydrides (NCAs) from the backbone polymers bearing amine functional 
groups.[10-12] However, amine-initiated NCA polymerization involves complex 
mechanisms and give polypeptides with poorly controlled molecular weights (MWs). In 
Chapter 2 and 3, I reported a new type of controlled NCA polymerization initiated by N-
trimethylsilyl (N-TMS) group (Scheme 4.1);[13-14] in this Chapter I report here the 
integration of this controlled NCA polymerization with ROMP to allow unprecedented, 
one-pot synthesis of brush-like polymers bearing polypeptides as the brush side chains.   
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4.2 Materials and Methods 
4.2.1 General 
All chemicals were purchased from Sigma-Aldrich (St. Louis, Mo) unless 
otherwise specified. Anhydrous dimethylformamide (DMF) was dried by two columns 
packed with 4 Å molecular sieves (MS). Dichloromethane (DCM) and tetrahydrofuran 
(THF) were dried by an alumina column and stored in a glove box.  Anhydrous CDCl3 
was prepared by treating regular CDCl3 (Sigma, St. Louis, Mo) in CaSO4 overnight 
followed by distillation under nitrogen.  The purified CDCl3 was stored in the presence of 
4Å MS.  TFA-d was purchased from Alfa-Aesar (Ward Hill, MA).  H-Glu(OBn)-OH and 
H-Lys(Z)-OH were purchased from Chem-Impex International (Des Plaines, IL) and 
used as received. C1,[15] C2,[15] NCAs, M1, M2 and M4 [14]were prepared by following 
previous reported procedures.  
 
NMR spectra were recorded on a Varian UI400 MHz, UI500NB MHz or on a 
VXR-500 MHz spectrometer.  Tandem gel permeation chromatography (GPC) was 
performed on a system equipped with an isocratic pump (Model 1100, Agilent 
Technology, Santa Clara, CA), a DAWN HELEOS 18-angle laser light scattering 
detector (Wyatt Technology, Santa Barbara, CA) and an Optilab rEX refractive index 
detector (Wyatt Technology, Santa Barbara, CA). The detection wavelength of HELEOS 
was set at 658 nm.  Separations were effected by series connected size exclusion columns 
(100 Å, 500 Å, 103 Å and 104 Å Phenogel columns, 5 µm, 300 × 7.8 mm, Phenomenex, 
Torrance, CA) at 60 °C using DMF containing 0.1 M LiBr as the mobile phase. The 
MALLS detector is calibrated using pure toluene with no need for external polymer 
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standards and can be used for the determination of the absolute molecular weights of both 
linear polymer and branched polymers. The molecular weights of all polymers were 
determined based on the dn/dc value of each sample calculated offline by using the 
internal calibration system processed by the ASTRA V software version 5.1.7.3 provided 
by Wyatt Technology.[16-17] All polymer samples were prepared at 10 mg/mL using DMF 
containing 0.1M LiBr. Twenty microliters of such solution (0.2 mg sample) was injected 
into GPC for each analysis. The low resolution electrospray ionization mass spectrometry 
(ESI-MS) was performed on a Waters Quattro II Mass Spectrometer.  Laser 
Desorption/Ionization-Time Of Flight mass spectrometry (MALDI-TOF MS) spectra 
were collected on a Applied Biosystems Voyager-DETM STR system. Infrared spectra 
were recorded on a Perkin Elmer 100 serial FT-IR spectrophotometer calibrated with 
polystyrene film. CD spectra were recorded on a JASCO J-700 Circular Dichroism 
Spectrometer. The TEM experiments were performed on a Philips EM300 Electron 
Microscope at an accelerating voltage of 80 kV.   
 
4.2.2 Brush polymer synthesis 
4.2.2.1 General procedure of ROMP copolymerization.        In a dry box, M2 (22 mg, 
0.08 mmol) and M4 (51 mg, 0.2mmol) were mixed in anhydrous THF (0.9 mL).  
Ruthenium catalyst C1 (3.5 mg, 0.004 mmol) in DCM (0.1 mL) was added to the 
monomer mixture.  The reaction was stirred at room temperature for 30 min. After the 
reaction was completed (monitored by TLC), the reaction was quenched by pouring the 
reaction mixture to ethyl vinyl ether (2 mL) to terminate the ROMP.  The precipitated 
solid was collected by centrifugation, washed with diethyl ether (3 × 2 mL) and dried 
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under vacuum (82-90 % isolated yield). The Mn and molecular weight distribution 
(MWD = Mw/Mn) were 1.62 × 104 g/mol and 1.04, respectively (dn/dc = 0.134).  1H 
NMR (CDCl3, 500 MHz): δ7.38-7.22, 5.59, 4.61, 3.50, 3.21, 2.90, 1.86-1.62, 1.22-0.98.  
The 1H NMR spectrum of the resulting polymer before quenching with ethyl vinyl ether 
was recorded to confirm the presence of TMS group.  
 
4.2.2.2  General procedure for transferring N-TMS amine group of the ROMP 
Polymer to NH-Boc       To obtain GPC signal of homo-polymer of M2 (P4 and P5), the 
tethered NH-TMS group of the polymer has to be transferred to more inert groups such as 
NH-Boc. Generally, after the polymerization of M2 (14 mg. 0.05 mmol) at a M/I ratio of 
100/1 catalyzed by C1 in THF (0.5 mL) for 2 h, ROMP was quenched by adding ethyl 
vinyl ether  (0.1 mL) and MeOH (0.1 mL) to the solution. (Boc)2O (50 mg, 0.23 mmol) 
was added to the solution. The mixture was stirred overnight at room temperature. 
Petroleum ether (5 mL) was added to precipitate the polymer. The precipitates was 
collected by centrifuge and washed by petroleum ether twice (5 mL) followed by vacuum 
dry. The polymer was dissolved in CDCl3 for 1H NMR analysis, almost 100 % efficiency 
of the NH-TMS group transformation to NH-Boc was observed. Good S/N in GPC was 
observed.  The Mn and MWD were 2.76 × 104 g/mol and 1.13, respectively (dn/dc = 
0.136).   
 
4.2.2.3    General procedure for the preparation of brush-like polymers.        In a dry box, 
M2 (14.5 mg, 0.05 mmol) and M4 (75 mg, 0.3 mmol) were mixed in anhydrous THF (1 
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mL).  Ruthenium catalyst C1 (4.4 mg, 0.005 mmol) in DCM (0.1 mL) was added to the 
monomer mixture. The reaction was stirred at room temperature for 1 h. After M2 and 
M4 were completely consumed (monitored by TLC), THF was removed under vacuum in 
the glove box. Anhydrous DMF (1 mL) was added to dissolve the resulting polymer (P4) 
followed by addition of Glu-NCA (395 mg, 1.5 mmol) in DMF (2 mL). After the Glu-
NCA was completely consumed (monitored by following the anhydride band of NCA at 
1790 cm-1) by FT-IR, the ruthenium catalyst was removed by pouring the reaction 
mixture to ethyl vinyl ether (5 mL). The resulting polymer (P4-g-Glu30) was precipitated 
with diethyl ether (20 mL), collected by centrifugation, washed with diethyl ether (3 × 20 
mL) and dried under vacuum (68-75% isolated yield). The Mn and MWD of P4 were 1.25 
× 104 g/mol and 1.02, respectively (dn/dc = 0.134).  The Mn and MWD of brush polymer 
P4-g-Glu30 were 5.51× 104 g/mol and 1.05 respectively (dn/dc = 0.110). The dn/dc value 
of brushed polymers verified from 0.11 to 0.095 depending on the polypeptide chain 
lengths. 1H NMR (CDCl3/TFA-d mixture (v/v: 85/15 to 50/50), 500 MHz): δ8.24, 7.39-
7.25, 5.59-5.40, 5.08, 4.61, 4.57, 3.50, 2.90, 2.44, 2.11, 1.92, 1.18.   
4.2.3 General protocol of Kinetic Study       
The kinetic study was performed by monitoring the NCA anhydride band at 1787 
cm-1 using FT-IR using a volume constant KBr cell. A standard working curve was firstly 
plotted using the same FT-IR instruments and the same KBr cell at different Glu-NCA 
concentrations. 
 
4.2.3.1  Kinetic study of M2 initiated Glu-NCA polymerization      in a glove box, Glu-
NCA (156 mg, 0.6 mmol) was dissolved in dry DMF (3.0 mL). The initial NCA 
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concentration was 52 mg/mL. M2 stock solution at (0.1 M in DMF, 60 µL) was added to 
the Glu-NCA solution. The M/I of NCA polymerization is 100/1. The reaction was 
monitored by taking 500 µL solution out of the box each time for FT-IR analysis at 
certain time intervals.    
 
4.2.3.2     Kinetic study of ROMP polymer initiated Glu-NCA polymerization       In a 
glove box, M4 (25 mg, 0.1 mmol) and M2 (7.8 mg, 0.03 mmol) were dissolved in dry 
THF (0.6 mL). Grubbs catalyst C1 stock solution in THF (0.01 M × 0.1 mL) was added 
to the solution in one portion. The mixture was stirred at r.t. for 2 h followed by 
evaporation of the solvent under high vacuum for 2 h. DMF (300 µL) was added to 
dissolve the polymer to preapare a stock solution with NHTMS concentration of 0.1 M. 
The ROMP stock solution (0.1 M in DMF, 60 µL) was added in one portion into a Glu-
NCA (156 mg, 0.6 mmol) solution in DMF (3.0 mL) under stirring.  The reaction was 
monitored by taking 500 µL solution out of the box each time for FT-IR and GPC 
analysis at certain time intervals. 
 
4.2.4 Circular dichroism (CD) study       
The CD measurements were recorded on JASCO J-700 Circular Dichroism 
Spectrometer at 25 oC. The cell length is 0.1 cm. The solvent background was subtracted 
from the original spectra. Homopolymer and copolymer are dissolved in TFE 
(trifluoroethanol) with a concentration of 2 mg/mL. 
 
4.2.5 Micelles formation and TEM analysis    
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For the micelle preparation, P4-g-Glu30 (0.45 mg) was dissolved in DMF (0.5 mL) 
followed by dropwise addition of methanol (0.25 mL) under ultrasonication. Strong 
Tyndall light scattering was observed when a laser beam passed through the dispersion, 
indicating formation of assemblies or aggregates. This sample was then analyzed by 
TEM. The solution was first cast onto a carbon-coated copper grid and allowed to air dry 
at room temperature. The samples were then stained with RuO4 vapor at room 
temperature for 30 min before the TEM analysis. 
 
4.3 Results and Discussion  
4.3.1 Synthesis of polypeptides-bearing brush-like polymers  
Three NCAs (γ-benzyl-L-glutamate NCA (Glu-NCA), ε-CBZ-L-lysine NCA 
(Lys-NCA), and L-leucine NCA (Leu-NCA) (Scheme 4.1)), two Grubbs’ catalysts (C1 
and C2, Scheme 4.1),[15, 18]  and three norbornene compounds (5-norbornene-endo-2,3-
dicarboximide (M1) and its derivatives (M2 and M4) (Scheme 4.2)) were involved in this 
study.  To facilitate controlled NCA polymerization, the polymer backbone derived from 
ROMP should have the desired N−TMS group.[14]  I first attempted to prepare such 
polymers by ROMP of an amino-containing norbornene (M1) or a monomer mixture (M1 
and M4) (Approach 1, Scheme 4.2).  No ROMP of M1 was observed in the presence of 
either C1 or C2.  1H NMR analysis indicated that M1 remained largely intact (>97%) 
presumably due to the deactivation of C1 or C2 by the amine of M1 (entry 1, Table 
4.1).[19]  I also attempted the “grafting through” strategy (Approach 2, Scheme 4.2).  M2 
was first utilized to polymerize Glu-NCA to make the norbornene-terminated polypeptide 
macromonomer (M3) that contains the desired N-TMS groups (Table 4.2).  However, 
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when this macromonomer was utilized for ROMP, polymers with uncontrolled MWs and 
broad molecular weight distributions (MWDs) were obtained in all attempts at various 
monomer/initiator (M/I) ratios (data not shown).    
 
TMS can be used as an amine-protection group as amine-TMS has reduced 
activity compared to the parental amine. I reasoned that the N-TMS containing 
norbornene derivative M2 likely made a successful ROMP monomer and the resulting 
ROMP polymers might function as macromolecular initiators for subsequent NCA 
polymerization (Approach 3, Scheme 4.2).  As expected, poly(norbornene dimide)s with 
well controlled Mn’s were obtained in C1-mediated polymerization of M2 (entries 2-5, 
Table 4.1).  Polymerizations at a M/I ratio of 11 and 20 resulted in P2 and P3 with an 
Mn’s of 2.0 ×103 g/mol and 3.5 ×103 g/mol, respectively, which were in good agreement 
with the expected Mn’s (2.3 ×103 g/mol and 4.1 ×103 g/mol, respectively). Both polymers 
had very low MWDs (Mw/Mn ≈ 1.1).  Similar results were obtained at higher ratio (50/1 
and 100/1) of C1 mediated M2 polymerization (P4 and P5, Table 4.1). C1 displayed 
remarkable activity and completed the polymerization within 30 min.  In order to control 
the polypeptide grafting density and the architecture of the desired brush-like polymers, I 
evaluated the random copolymerization of M2 with co-monomer M4 (P6-P10, Table 4.1).  
Well controlled polymerizations were observed at all M2/M4 ratios studied with the use 
of either C1 or C2.  The resulting polymers all have well-controlled Mn’s and low MWDs 
(Mw/Mn = 1.02 - 1.14). 1H NMR studies confirmed the presence of TMS functional group 
in these polymers (Figure 4.1).   
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I then tested whether these polymers could be used as initiators for controlled 
NCA polymerization.  Generally, polynorbornenes containing N-TMS amine group were 
first prepared.  After the solvent (THF) of ROMP and the dissociated pyridine ligand 
from the Grubbs catalyst were removed under vacuum, DMF was added to the residual 
polymers followed by addition of Glu-NCA at various NCA/M2 ratios (entries 1-3, Table 
4.3).  The NCA polymerizations initiated by the N-TMS amine group of ROMP polymers 
proceeded in a manner resembling the small molecule N−TMS amine initiated NCA 
polymerizations that I previously reported,[13-14]  and gave Pn-g-poly(γ-benzyl-L-
glutamate) (PBLG) with expected Mn’s and narrow MWDs.  The polynorbornene-g-
PBLG was denoted as Pn-g-Glum, where “Pn” corresponds to the poly(norbornene) 
shown in Table 4.1 and “m” is the Glu-NCA/M2 ratio.  Monomodal GPC distribution 
patterns were observed with all three brush-like polymers derived from P2 with different 
PBLG chain lengths (Figure 4.2b). PBLG side chains with as short as 20 repeating units 
could be readily obtained (data not shown). Controlled NCA polymerizations were also 
observed with the use of random copolymer as macroinitiators.  The statistical copolymer 
P7, with a M2/M4/C2 feeding ratio of 10:50:1 was used as the initiator for Glu-NCA 
polymerization. The resulting P7 has an M2/M4/C2 ratio of 6:42:1. At a Glu-NCA/M2 
ratio of 30, P7-g-Glu30 with a Mn of 5.51 ×104 g/mol was obtained, which corresponded 
to a degree of polymerization of 32 (entry 6, Table 4.3). GPC analyses of P7 and P7-g-
Glu50 demonstrated the formation of brush-like polymer (Figur 4.2a).This technique can 
be expanded to other type of NCAs.  When the polymerization of Lys-NCA was 
mediated by P7 at a Lys-NCA/M2 ratio of 30, P7-g-Lys30 with the expected MW and a 
very narrow MWD were obtained (entry 7, Table 4.3).  Brush-like polymers containing 
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block copolypeptide as the brush side chains could also be readily prepared through this 
one-pot polymerization strategy.  Sequential addition of Glu- and Leu-NCA to P10 at a 
Glu-NCA/(M2) ratio of 30 and a Leu-NCA/(M2) ratio of 10, respectively, resulted in 
formation of P10-g-(Glu30-b-Leu10) brush-like polymer with anticipated composition and 
MW, and narrow MWD (entry 9, Table 4.3).   
 
4.3.2 Kinetic study  
To prove the mono dispersity of polypeptides brushes, kinetic study was 
performed in P8 initiated Glu-NCA polymerization at NCA/M2 of 100:1. By comparing 
the two polymerization kinetics profiles, the consumption of Glu-NCA were found to be 
first order for both M2 and random polymer P8 initiated polymerization at M/I of 100. In 
the M2 initiated NCA polymerization, the kinetic equation can therefore be described as: 
 
     -d[Glu-NCA]/dt = Kp[NHTMS][Glu-NCA] = Kp’[Glu-NCA]                          (1) 
 
where Kp[NHTMS] = Kp’ and Kp’ is the slope of the curve in Figure 4.3c. 
Similarly, the kinetic equation of P8 initiated NCA polymerization can therefore be 
written as 
 
      -d[Glu-NCA]/dt = (Kp)P8[NHTMS]P8[Glu-NCA] = (Kp)’P8 [Glu-NCA]               (2) 
 
Where (Kp)’P8 = (Kp)P8[NHTMS]P8 and (Kp)’P8 is the slope of Fig. 4.3a. Therefore, 
by definition 
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(Kp)’P8/ Kp’ = (Kp)P8[NHTMS]P8/Kp[NHTMS].                             (3) 
 
If we assume (Kp)P8 = Kp, then equation (3) can be simplified as (Kp)’graft/ Kp’ = 
[NHTMS]P8/[NHTMS].  From Figure 4.3c and 4.3a, the slopes are 0.198 and 0.159, 
respectively. Therefore  
 
[NHTMS]P8/[NHTMS] =(Kp)’graft/ Kp’ =0.159/0.198 =80 %                        (4) 
 
Equation (4) indicated that 80% of the NHTMS in the polymer was actively 
involved in initiating NCA polymerization. But given that N-TMS amine group is 
confined in the polymer chain in P8-initiated NCA polymerization, (Kp)P8 must be 
smaller than Kp.  Therefore the real initiator (N-TMS amine) in P8 must be larger than 
80%. Furthermore, the Figure 4.3b showed the linear correlation of the Mn values of P8-
g-Glu100 with the conversions of NCA monomer, indicating the consumption of NCA and 
elongation of the polypeptide side chain are in a highly controlled pattern. 
 
4.3.3 Characterization of polypeptides-bearing brush-like polymers   
To investigate the secondary structure of the brush polymers, P6-g-Glu30 and P3-
g-Glu50 were analyzed by Circular Dichroism (CD) and 1H-NMR spectroscopy. α-Helical 
structures were observed for both polymers. In Figure 4.4, the peaks at 208nm and 222 
nm in CD spectra indicate the existence of helical structures in trifluoroethanol (TFE). 
The helical strcture is also confirmed by the 1H NMR spectrum in Figure 4.5. The 
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broadening of the PBLG peaks from TFA-d to DMF-d7 and the change of chemical shift 
indicated the change of the secondary structure of PBLG from random coils to α-helices.  
Brush-like hybrid polymers may form aggregates in sub-100 nanometers scale, such as 
micelles.[20] When methanol was added into a DMF solution of P7-g-Glu30, the colorless 
solution turned slightly blue coupled with strong light scattering, suggesting the 
formation of aggregates. The analyses of these aggregates using TEM revealed that they 
adopted spherical structures with sizes around 60-150 nm (Figure 4.6).   
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Scheme 4.2 
 
 
 
Table 4.1 Poly(norbornene diimide)s Prepared by ROMP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
aMn = the obtained Mn, Mn* = the expected Mn; determined by GPC unless otherwise specified; 
bdetermined by MALDI cmeasured by GPC after converting the -NHTMS of the polymers to -
NHBoc (SI). drandom copolymerization, M4/M2 = 60/20 (P6), 50/10 (P7), 100/10 (P8), 50/20 (P9) 
and 60/30 (P10). 
 
 
 
 
 
 
 
 
 
 
 
 
O
R
N
H
 polymer catalyst monomer(s) Mtot/I M n
  
(M n*) a (x 103 g/mol) MWD (M w/ M n)
P1 C1 M1 60 no reaction /
P2 C1 M2 11 2.0 (2.3) b 1.13 
P3 C1 M2 20 3.5 (4.1) b 1.27 
P4 C1 M2 50 12.5 (15.3) c 1.20 
P5 C1 M2 100 27.6 (30.6) c 1.13 
P6 C1 M2+M4 d 80 19.3 (19.2) 1.07 
P7 C2 M2+M4 d 60 12.5 (14.9) 1.02 
P8 C1 M2+M4 d 130 29.9 (31.4) 1.11 
P9 C1 M2+M4 d 70 16.2 (16.7) 1.04 
P10 C1 M2+M4 d 90 23.4 (21.2) 1.04 
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Table 4.2 M2 Initiated NCA Polymerization in DMF at Room Temperature 
 
entry M (M/I) M n (expected) (x 103 g/mol)
M n (obtained) 
(x 103 g/mol) M w/M n
1 Glu-NCA (50) 10.9 12.3 1.15
2 Glu-NCA (100) 21.9 23.8 1.17
3 Glu-NCA (200) 43.8 43.3 1.15
4 Lys-NCA (50) 13.1 13.3 1.09
5 Lys-NCA (100) 26.2 22.7 1.04
6 Lys-NCA (200) 52.4 41.2 1.05
 
 
 
 
 
 
Table 4.3  Synthesis of Poly(norbornene)-g-Polypeptides 
 
entry polymer cat. x (x*)a y (y*)b NCA n (n*)c M n (M n*)
d  
(x 104 
MWD 
(M w/M n)
1 P2-g -Glu50 C1 9 (11)e 0 Glu 50 (50) 10.0 (12.3) 1.05 
2 P2-g -Glu100 C1 9 (11)e 0 Glu 113 (100) 22.5 (24.3) 1.10 
3 P2-g -Glu200 C1 9 (11)e 0 Glu 185 (200) 38.7 (48.4) 1.14 
4 P3-g -Glu50 C1 17 (20)e 0 Glu 50 (50) 19.1 (22.3) 1.15 
5 P6-g -Glu30 C1 23 (20) 58 (60) Glu 34 (30) 19.0 (15.1) 1.03 
6 P7-g -Glu30 C2 6 (10) 42 (50) Glu 32 (30) 5.5 (8.0) 1.05 
7 P7-g -Lys30 C2 6 (10) 42 (50) Lys 37 (30) 7.2 (9.3) 1.13 
8 P8-g -Glu100 C1 28 (30) 95 (100) Glu 81 (100) 52.5 (57.0) 1.04 
9
P10-g -(Glu30-
b -Leu10) C1 28 (30) 70 (60)
Glu 
+Leu
25/7 
(30/10)f 19.7 (25.2) 1.13 
 
 
a
x = the obtained degree of polymerization (DP) of poly(M2), x* = the expected DP of poly(M2); 
by = the obtained DP of poly(M4), y* = the expected DP of poly(M4); cn = the obtained DP of 
polypeptides, n* = the expected DP of polypeptides; dMn = the obtained Mn determined by GPC, 
Mn* = the expected Mn calculated from the feeding ratio; edetermined by MALDI-TOF MS; 
fdetermined by GPC and 1H NMR; g the obtained DP of PBLG/the obtained DP of poly(Leu)(the 
expected DP of PBLG/the expected DP of poly(Leu)). Determined by GPC and 1H NMR 
 
 
 
 
 
 
 
 
 
53 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 The 1H NMR spectrum of the random copolymer poly(M2/M4) in anhydrous 
condition. The M4/M2 ratio was 50:30. After polymerization the solvent (THF) was removed 
under vacuum; anhydrous CDCl3 then was added to dissolve the resulting poly(M2/M4) under 
argon. The NMR spectrum was collected on a UI500NB NMR spectrometer. 
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Figure 4.2 (a) GPC overlay of the P2-g-Glu50, P2-g-Glu100 and P2-g-Glu200; (b) GPC overlay of 
P7 and P7-g-Glu30  
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Figure 4.3  a) Kinetic profile of P8 initiated NCA polymerization at NCA/M2 of 100/1. The 
initial NCA concentration is 52 mg/mL. The slope of the curve is 0.159. b) the plot of Mn of  P8-
g-Glu100 versus conversion of NCA. c) Kinetic profile of the M2 initiated NCA polymerization at 
NCA/M2 of 100/1. The initial NCA concentration is 52 mg/mL. The slope of the curve is 0.198.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 CD analysis of PBLG grafted ROMP polymers (P6-g-Glu30 and P3-g-Glu50) in TFE. 
The concentration is 2.0 mg/mL for P6-g-Glu30 and 1.8 mg/mL for P3-g-Glu50. 
 
 
 
 
 
time (h)
ln
(C
0/C
)
0
0.5
1
1.5
2
2.5
3
0 5 10 150
0.5
1
1.5
2
0 5 10 15
0
200000
400000
600000
 
time (h)
ln
(C
0/C
)
Conv.
M
n
x 
10
 
-
5
M
W
D
expected
obtained
0 0.2 0.4 0.6 0.8 1
2
0
4
6
1.0
1.1
1.2
1.3
1.4
1.5
a b c 
CD measurements
180 190 200 210 220 230 240 250 260 270
-60
-50
-40
-30
-20
-10
0
10
20
30
40
50
60
70
80
90
 
 
[θ]
(10
3  
de
g 
cm
2 /d
 
m
o
le
)
λ (nm)
 N56-4  in TFE
 N58-3  in TFE
P6-g-Glu30
P3-g-Glu50
55 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 1H NMR spectrum of the brush polymer P6-g-Glu30 (10 mg/mL) in DMF-d7 and TFA-
d. The chemical shift in DMF-d7 and TFA-d are normalized by the chemical shift of the phenyl 
ring. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6 TEM analysis of nanoaggregates of P7-g-Glu30. Inset: (Left) a solution of P7-g-Glu30 
in DMF; (Right) a solution of P4-g-Glu30 micelles in a mixture of MeOH/DMF. 
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4.4 Conclusions 
 
In conclusion, I developed an unprecedented strategy of integrating ROMP and 
ROP of NCAs for making brush-like polymers containing ROMP polymer backbone and 
polypeptide or co-polypeptide brushes in a high controlled manner. Given that numerous 
ROMP and NCA monomers are widely available, we believe this novel polymerization 
technique will allow easy access to numerous hybrid materials with broad utilities. 
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CHAPTER 5 
FUNCTIONAL POLYPEPTIDES: VB-GLU-NCA AND PVBLG  
5.1   Introduction 
Synthetic polypeptides are a class of biomaterials that have shown great potential 
in various biological and biomedical applications.[1-9] Synthesis of polypeptides with high 
molecular weights (MWs) in large scale is usually achieved via ring-opening 
polymerizations (ROP) of α-amino acid N-carboxyanhydrides (NCAs).[10-19] 
Theoretically, all 20 natural amino acids can be used for the preparation of NCAs, which 
can subsequently be used for the synthesis of polypeptides bearing protein-like side 
chains[20-23] or polypeptide-containing hybrid polymers[19, 24-25]. However, because of the 
difficulty in the synthesis and purification of the majority of these NCA[26] as well as the 
poor solubility of many polypeptides derived from the ROP of these NCAs,[27-28] only a 
limited number of NCA monomers have been used frequently for the synthesis and 
studies of polypeptides.  One such monomer is γ-benzyl-L-glutamate NCA (Glu-NCA).  
Glu-NCA can be readily prepared in large-scale and high purity as well as polymerized to 
yield poly(γ-benzyl-L-glutamate) (PBLG), which is by far the most intensively 
investigated synthetic polypeptide because of its excellent solubility in common organic 
solvents and a variety of unique properties (e.g., helical conformation, liquid crystal, 
etc.).[5, 29-30]   
 
Once formed, however, PBLG has limited tunability of its properties because of 
the lack of side chain functionality.  To alter the properties of PBLG via side chain 
modification, one common approach is to remove the benzyl ester of PBLG and then 
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conjugate the desired side chain moieties to the resulting poly(L-glutamate) (PLG).  
Unfortunately, this approach often involves the use of harsh deprotection chemistry (e.g., 
33% HBr or TMSI) and has poor conjugation efficiency,[31-32] especially in the case of 
high-MW PBLG. An alternative method to prepare side-chain modified PLG is via the 
synthesis and polymerization of Glu-NCA analogues bearing the desired side chains.  
However, such an approach is rarely pursued due to the difficulty in the synthesis, 
purification and handling of the corresponding Glu-NCA analogues.[33-36] The control 
over the polymerization of these monomers may also vary case by case, thus making it is 
very unlikely to become a general strategy for creating a set of polypeptide materials 
bearing PLG backbone. Transesterification or aminolysis may also be used to modify 
PBLG, but this strategy usually requires the use of excessive amounts of alcohol or amine 
and very long reaction times with variable, sometimes uncontrolled, conjugation 
efficiency.[37-43] An emerging approach is to develop new Glu-NCA monomers bearing 
highly efficient, conjugation-amenable functional groups that stay intact during 
polymerization and can be used for grafting of the moieties of interest after 
polymerization.  To date, there has been a limited set of such Glu-NCA monomers 
prepared and used for generating side chain modified PBLG.  The few examples that 
exist in literature include γ-alkenyl-L-glutamate NCA,[44] γ-propargyl-L-glutamate 
NCA[45-46] and γ-3-chloropropanyl-L-glutamate NCA.[47]  
 
In this Chapter, I report the synthesis and controlled polymerization of γ-(4-
vinylbenzyl)-L-glutamate N-carboxyanhydride (VB-Glu-NCA) and utilization of the 
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resulting poly(γ-(4-vinylbenzyl)-L-glutamate) (PVBLG) to prepare a variety of PBLG 
analogues with functional groups of interests. 
 
5.2    Materials and Methods 
5.2.1  General 
All chemicals were purchased from Sigma-Aldrich (St. Louis, Mo, USA) and 
used as received unless otherwise specified. Anhydrous dimethylformamide (DMF) was 
dried by two columns packed with 4Å molecular sieves and stored in a glove-box. 
Tetrahydrofuran (THF) and hexane were dried by a column packed with alumina and 
stored in a glove-box. All chemicals were purchased from Sigma-Aldrich (St. Louis, Mo, 
USA) and used as received unless otherwise specified. Dry nitrobenzene (NB) was 
prepared by treating regular NB by CaH2 followed by distillation under reduced pressure. 
H-Lys(Z)-OH and H-Glu(OBn)-OH were purchased from Chem-Impex International 
(Des Plaines, IL, USA) and used as received. Glu-NCA and Lys-NCA were prepared by 
following previously reported procedures.[13] NMR spectra were recorded on a Varian 
UI400 MHz, a UI500NB MHz or a VXR-500 MHz spectrometer.  Tandem gel 
permeation chromatography (GPC) experiments were performed on a system equipped 
with an isocratic pump (Model 1100, Agilent Technology, Santa Clara, CA, USA), a 
DAWN HELEOS 18-angle laser light scattering detector (also known as multi-angle 
laser light scattering (MALLS) detector, Wyatt Technology, Santa Barbara, CA, USA) 
and an Optilab rEX refractive index detector (Wyatt Technology, Santa Barbara, CA, 
USA). The detection wavelength of HELEOS was set at 658 nm.  Separations were 
performed using serially connected size exclusion columns (100Å, 500Å, 103Å and 104Å 
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Phenogel columns, 5 µm, 300 × 7.8 mm, Phenomenex, Torrance, CA, USA) at 60°C 
using DMF containing 0.1 M LiBr as the mobile phase. The MALLS detector was 
calibrated using pure toluene with no need for external polymer standards and can be 
used for the determination of the absolute molecular weights. The molecular weights 
(MWs) of all polymers were determined based on the dn/dc value of each sample 
calculated offline by using the internal calibration system processed by the ASTRA V 
software (version 5.1.7.3, Wyatt Technology, Santa Barbara, CA, USA).  Infrared spectra 
were recorded on a Perkin Elmer 100 serial FTIR spectrophotometer calibrated with 
polystyrene film. Circular dichroism (CD) measurements were carried out on a JASCO J-
720 CD spectrometer (Jasco Analytical Instruments, Easton, MD, USA). Ozone was 
produced by an OZV-8S ozone generator manufactured by Ozone Solutions Inc (Hull, IA, 
USA). Lyophilization was performed on a FreeZone lyophilizer (Labconco, Kansas City, 
MO, USA).  UV light was generated from an OmiCure S1000 UV lamp (EXFO, 
Mississauga, Canada). Small angle X-ray scattering (SAXS) data were collected in a 
helium chamber using a Bruker M18XHF22 (Bruker Axs Inc. Madison, WI, USA) 
rotating anode generator operating at 50kV and 50mA supplying a Cu Kα (λ = 1.541838 
Å) radiation beam that was collimated using a pinhole collimator. 
 
5.2.2   Preparation and polymerization of VB-Glu-NCA  
5.2.2.1 Synthesis of γ-(4-vinylbenzyl)-L-glutamate NCA (VB-Glu-NCA)    γ-(4-
vinylbenzyl)- L-glutamate (VB-Glu) was synthesized by following a reported procedure 
with slight modification. VB-Glu (2.45 g, 10 mmol) was dried under vacuum for 2 h.  
This solid was suspended in anhydrous THF (30 mL). Phosgene (20% in toluene, 7 mL) 
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was added under nitrogen to the suspension dropwise over the course of 5 min.  The 
suspension was stirred at 50 oC for 2-3 h.  The solvent was removed under vacuum. The 
residue was dissolved in anhydrous THF (20 mL) in a glove box and centrifuged to 
remove the undesired byproducts.  The supernatant was combined and the solvent was 
removed under vacuum. The residue (containing a mixture of NCA and some dark 
colored impurity) was dissolved in THF (10 mL) followed by the addition of anhydrous 
ether (100 mL).  The solution was cooled at -30 oC in the box. A dark oily residue was 
removed. The clear solution containing NCA was combined and concentrated. VB-Glu-
NCA in white crystalline form (3.4 mmol, 1.0 g, 34% yield) was obtained through 
recrystallization three times using THF/Hexane. 1H NMR (CDCl3, 500 MHz): δ 7.40 (d, 
2H,  J =8.0 Hz, ArH), 7.30 (d, 2H, J =8 Hz, ArH), 6.73-6.67 (m, 2H, NH and 
C6H4CH=CH2), 5.76 (d, 1H, J =17.5 Hz, C6H4CH=CH2), 5.27 (d, 1H, J =11 Hz, 
C6H4CH=CH2), 5.11 (s, 2H, ArCH2), 4.38 (t, 1H, J =6.0 Hz, CHCH2CH2COOCH2), 2.58 
(t, 2H, CH2CH2COOCH2), 2.26 (m, 1H, CH2CH2COOCH2), 2.12 (m, 1H, 
CH2CH2COOCH2). 13C NMR (CDCl3, 500 MHz): δ 172.4, 169.3, 151.9, 137.8, 136.1, 
134.6, 128.6, 126.4, 114.6, 66.8, 56.9, 29.8, 26.8. ESI MS analysis (with NaCl) Calcd: 
m/z 289.2 (M); found: m/z 312.3 (M+Na). Anal. Calcd. For C15H15NO5: 62.29%C, 
5.21%H, 4.84%N; found: 62.06%C, 5.12%H, 4.83%N. 
 
5.2.2.2 General procedure for the VB-Glu-NCA polymerization         In a glove-box VB-
Glu-NCA (29 mg, 0.1 mmol) was dissolved in a mixture of DMF (450 µL) and 
nitrobenzene (30 µL).  The VB-Glu-NCA solution was added to a DMF solution of 
HMDS (20 µL, 0.1 mmol/mL).  The reaction mixture was stirred for 15 h at room 
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temperature. An aliquot of the polymerization solution was diluted to 10 mg PVBLG/mL 
using DMF (containing 0.1 M LiBr), and then analyzed by GPC to determine the MW, Mn.  
The N-terminus of the polymer was capped by treating the polymerization solution in situ 
with tetrabutylammonium fluoride solution (1.0 M × 50 µL), diisopropylethylamine (30 
µL) and benzyl chloroformate (0.1 mL) for 2-3 h.  The majority of the DMF was then 
removed under vacuum. The residue was precipitated with ether (15 mL).  The obtained 
PVBLG was sonicated for 5 min in ether (5-10 mL) and centrifuged to remove the 
solvent. After the sonication-centrifugation procedure was repeated two more times, 
PVBLG was collected, dried under vacuum and stored in -20oC freezer. 1H NMR (TFA-d, 
500 MHz): δ 7.53 (d, 2H, J =7.0 Hz, ArH), 7.39 (d, 2H, J =7.0 Hz, ArH), 6.84 (dd, 1H, J1 
=11.0 Hz, J2 =18.0 Hz C6H4CH=CH2), 5.91 (d, 1H, J =18.0 Hz, C6H4CH=CH2), 5.43 (d, 
1H, J =11.0 Hz, C6H4CH=CH2), 5.26 (m, 2H, ArCH2), 4.80 (m, 1H, 
CHCH2CH2COOCH2), 2.68 (m, 2H, CHCH2CH2COO), 2.30 (m, 1H, CHCH2CH2COO), 
2.12 (m, 1H, CHCH2CH2COO)  
 
5.2.2.3  Kinetic study of the polymerization of VB-Glu-NCA             In a glove box, VB-
Glu-NCA (172 mg, 0.6 mmol) was dissolved in DMF (3.0 mL). A stock solution of 
HMDS (0.1 M, 0.06 mL) was added to the stirred VB-Glu-NCA/DMF solution in one 
portion. The real-time concentration of NCA was quantified by measuring the intensity of 
the anhydride band at 1784 cm-1 by FT-IR.  The conversion of NCA was determined by 
comparing the NCA concentration in the polymerization solution versus the initial NCA 
concentration.  
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5.2.2.4 General procedure for synthesis of PZLL-b-PVBLG           In a glove box, Lys-
NCA (61 mg, 0.2 mmol) was dissolved in dry DMF (1.0 mL).  HMDS (0.1 M, in 100 µL 
DMF) was added to the stirred NCA solution. The reaction mixture was stirred for 16 h at 
room temperature and then an aliquot of the solution was used for GPC analysis.  VB-
Glu-NCA (145 mg, 0.5 mmol) dissolved in DMF/NB (1 mL/100 µL) was added to the 
rest of the PZLL polymerization solution. C2 (0.01 M × 20 µL) was then added to the 
mixture. The mixture was monitored by FT-IR and removed from the glove box after 
VB-Glu-NCA was completely consumed.  An aliquot of the polymerization solution was 
used for GPC analysis for the Mn and MWD of the resulting PZLL-b-PVBLG. The 
remaining solution was treated by TBAF (0.1M, 50 µL), diisopropylethylamine (10 µL) 
and benzyl chloroformate (20 µL) to protect the N-terminus. The solution was stirred at 
room temperature for 2-3 h followed by the removal of the majority of the solvent under 
vacuum. The residue was precipitated with ether (30 mL).  The obtained PZLL-b-
PVBLG was sonicated for 5 min in ether and centrifuged to remove the solvent.  After 
the sonication-centrifugation procedure was repeated two more times, PZLL-b-PVBLG 
was collected and dried under vacuum (108 mg, 62% yield) and analyzed by 1H NMR.  
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Scheme 5.1 Post-functionalization reactions of PVBLG.  
 
 
 
5.2.3   General procedure for the PVBLG Reactions (Scheme 5.1) 
5.2.3.1 Protocol of route a:    PVBLG70 (45 mg, 0.18 mmol) was dissolved in chloroform 
(15 mL) at -78oC.  O2 was bubbled into the solution for 1 min followed by bubbling of O3 
until the solution became blue, indicating the reaction was completed. O3 was then 
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replaced by O2, which was bubbled into the solution for another 2 min until the solution 
became colorless. The solution was then degassed and back filled with nitrogen. NaBH4 
(95 mg, 2.5 mmol) was then added to the mixture. The solution was stirred at room 
temperature overnight and the solvent was removed under vacuum. The residue oil was 
treated by cold water (10 mL) and stirred at room temperature for 1 h.  The polymer was 
collected by filtration and washed by DI water (5 mL × 2).  The resulting (PVBLG-a)70 
was freeze dried to give 33 mg white solid in 72% yield and analyzed by 1H NMR. 
 
5.2.3.2 Protocol of route b:    PVBLG70 (49 mg, 0.2 mmol) was dissolved in chloroform 
(15 mL) at -78oC. O2 was bubbled into the solution for 1 min followed by bubbling of O3 
until the solution became blue, indicating that the reaction was completed. O3 was then 
replaced by O2, which was bubbled into the solution for over the course of 2 min until the 
solution became colorless. The solution was then degassed and back filled with nitrogen. 
PPh3 (131 mg, 0.5 mmol) was then added to the mixture. The solution was stirred at room 
temperature for 2-3 h.  The solvent was removed under vacuum.  The resulting poly(γ-(4-
aldehydebenzyl)-L-glutamate) (PABLG or PVBLG-b) was purified by adding methanol 
followed by sonication (3 × 15 mL) to remove unreacted PPh3 and other impurities, 
lyophilized (39 mg, 78% yield) and analyzed by 1H NMR. 
 
5.2.3.3 Protocol of route c[48]: OsO4 (2.5 wt% in tert-butanol, 0.1 mL) and oxone (614 
mg, 2 mmol) were added to a solution of PVBLG70 (20 mg, 0.08 mmol vinyl) in DMF (1 
mL). The mixture was stirred at room temperature for 2 days. The excess oxone was 
quenched by Na2SO3 (200 mg, 1.6 mmol in 5 mL water). The solution was tuned to 
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slightly basic by the addition of 2M NaHCO3, dialyzed against water, and then 
lyophilized to give (PVBLG-c)70 as white solid (81% yield). 
 
5.2.3.4 Protocol of route d:  PVBLG70 (25 mg, 0.1 mmol vinyl group), OsO4 (2.5 wt% in 
tert-butanol, 0.1 mL) and N-methylmorpholine N-oxide (57 mg, 0.49 mmol) were stirred 
in acetone/H2O (v/v = 10:1; 1.5 mL total volume) for 20 h. The excess NMO was treated 
with Na2SO3 (126 mg, 1 mmol in 5 mL water). The solution was purified by dialysis 
against water and dried by lyophilization to give (PVBLG-d)70 as a white solid (22 mg, 
79% yield), which was analyzed by 1H NMR. 
 
5.2.3.5 Protocol of route e:   To a vigorously stirred mixture of acetone (1.0 mL) and a 
NaHCO3 solution (1.0 g in 2.0 mL water) in a 20-mL vial merged in an ice bath was 
added the solid oxone (1.1 g, 3.6 mmol) over the course of 3 min.  The vial cap was 
tightly closed throughout the reaction except when oxone was added. The mixture was 
stirred for another 5 min followed by the addition of PVBLG70 (25 mg, 0.1 mmol vinyl) 
in CH2Cl2 (2 mL). The mixture was stirred vigorously for 24 h.  Another portion of 
CH2Cl2 (2 mL) and DI water (5 mL) were added to dilute the mixture. The organic phase 
was collected and washed by brine (3 mL). The CH2Cl2 solution was dried by Na2SO4, 
filtered and concentrated under vacuum.  (PVBLG-e)70 in white solid form was obtained 
(18 mg, 69% yield) and analyzed by 1H NMR. 
 
5.2.3.6 Protocol of route f:  Grubbs catalyst (2nd generation, 2 mg, ca. 0.0025 mmol) and 
cis-1,4-dichloro-2-butene (0.2 mL, 1.9 mmol) were dissolved in dry CH2Cl2 (2 mL) in a 
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glovebox. PVBLG70 (25 mg, 0.1 mmol vinyl group) was added to the mixture via syringe. 
The solution was stirred at room temperature for 24 h. The solvent was removed under 
vacuum. The residue was washed by ether (2 × 10 mL) and dried under vacuum to give 
(PVBLG-f)70 as a light yellow oil (23 mg, 78 % yield). 
 
5.2.3.7 Protocol of route g:  PVBLG70 (25 mg, 0.1 mmol vinyl group) and 9-BBN (1 mL, 
0.5 M in THF) were mixed in dry THF (1 mL) under nitrogen. The solution was stirred at 
room temperature overnight. Pd(PPh3)4 (2 mg, ca. 0.0017 mmol), 4’-bromoacetophenone 
(100 mg, 0.5 mmol) and a NaHCO3 solution (3 M, 1 mL) were added under nitrogen. The 
mixture was stirred in a 70 oC oil bath for 20 h. The organic phase was collected, washed 
by a brine solution (10 mL), dried by Na2SO4, filtered, and concentrated under vacuum. 
The resulting product was washed by ether (10 mL × 2). The residue was dried under 
vacuum to give (PVBLG-g)70 (22 mg, 60% overall yield), which was analyzed by 1H 
NMR. 
 
5.2.3.8 Protocol of route h:  PVBLG70 (25 mg, 0.1 mmol vinyl group) was dissolved in 
THF (0.5 mL) containing 0.1% I2959 in a 7-mL glass vial. The solution was exposed to 
UV (365 nm, 20 mW/cm2) for 10 min till gelation was observed. 
 
5.2.4  Circular dichroism (CD analysis of (PVBLG-d)70   
The CD experiments were performed on a J-720 CD spectrometer. The solution 
was placed in a quartz disc with a light path of 0.5 cm. The mean residue molar ellipticity 
was calculated based on the ellipticity obtained, concentration of polymer and the molar 
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weight of the repeating unit ([θ] in deg·cm2·dmol-1) = (millidegrees × mean residue 
weight)/(pathlength in millimeters × concentration of polypeptide in mg·ml-1). 
 
5.2.5   Cytotoxicity Measurements    
The cytotoxicity of the polymers was characterized using the MTT cell viability 
assay (Sigma-Aldrich, St. Louis, MO, USA).  HeLa cells were seeded in 96-wells plates 
at 0.5 × 104 cells/well and grown overnight at 37 °C, 5% CO2  in medium containing 10% 
horse serum and 1% penicillin-streptomycin. Approximately 24 h after cell seeding, the 
medium was replaced with serum-supplemented DMEM and the polymer was added to 
the cells at known final concentrations. After 48 hours of incubation, the polymer 
solutions were removed and the cells were washed by PBS. Reconstituted 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT, 10 µL) was added.  The 
plates were then incubated for four hours and MTT solubilization solution (100 µL, 
Sigma-Aldrich, St. Louis, MO, USA) was added. The absorbance at 570 nm was 
recorded using a PerkinElmer 1420 multilable counter plate reader (Waltham, MA, USA).  
The background absorbance of cells killed with ethanol was subtracted from the viable 
cell absorbance and normalized to cells grown in DMEM. 
 
5.3 Results and Discussion 
5.3.1  Polymerization of VB-Glu-NCA in the presence of nitrobenzene (NB) 
 VB-Glu-NCA can be readily prepared in multi-gram scale in crystalline form 
(Figure 5.1) by following a slightly modified procedure.[49-50] The purified VB-Glu-NCA 
is very stable in moisture-free conditions and can be stored in a glove-box at -30 oC for 
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months without change of properties. I first attempted to use hexamethyldisilazane 
(HMDS), an initiator discovered in our previous studies that gives controlled ROP of 
Glu-NCA, to polymerize VB-Glu-NCA[13-14]  At a monomer/initiator (M/I) ratio of 50 
with the expected Mn of 1.22 × 104 g/mol, the resulting PVBLG has an Mn value of 1.87 
× 104 g/mol with a fairly broad molecular-weight distribution (MWD = Mw/Mn = 2.03) 
(entry 1, Table 5.1).  The control over polymerization differed distinctly from HMDS-
mediated Glu-NCA polymerization under similar condition, the latter of which usually 
gives PBLGs with obtained MWs in nearly perfect agreement with the expected MWs 
and much narrower MWDs (entry 2, Table 5.1).  I next performed the kinetic study of 
HMDS-mediated polymerizations of VB-Glu-NCA (Figure 5.2).  First-order propagation 
rate against monomer concentration in DMF was observed, suggesting that HMDS-
mediated VB-Glu-NCA polymerization follows a similar chain propagation mechanism 
as HMDS-mediated Glu-NCA polymerization but has relatively low activity toward 
polymerization. HMDS-mediated VB-Glu-NCA polymerization was found to proceed at 
a rate approximately 4 times lower than that of Glu-NCA polymerization under identical 
conditions.  The apparent propagation constant (kp’) of VB-Glu-NCA was determined to 
be 0.062 h-1 as compared to the  kp’ of 0.272 h-1 for the polymerization of Glu-NCA 
under similar conditions (Figure 5.2). From the gel permeation chromatography (GPC) 
curve of the obtained PVBLG (black, Figure 5.3), I noticed that the higher MW peak of 
the bimodal GPC curve has a strong light-scattering signal with a very weak refractive 
index signal (data not shown), suggesting the existence of a small portion of polymer 
with very high-MW.  As PVBLG is very soluble in DMF (the mobile phase of the GPC 
analysis) and very unlikely to form physical aggregates, I postulated that the formation of 
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the very high-MW PVBLG is due to the inter-chain cross-linking of the vinyl groups 
during HMDS-initiated polymerization.   
 
To prove this hypothesis, nitrobenzene (NB), an inhibitor of radical 
polymerization, was added to the HMDS-mediated VB-Glu-NCA polymerization 
solution. The initial monomer concentration in 0.5 mL solvent and the M/I ratio were 
fixed at 0.2 M and 50:1, respectively.  Thirty microliter of NB was added and the reaction 
was monitored by FT-IR till all the VB-Glu-NCA was consumed. As expected, the cross-
linking side reaction was completely inhibited.  The resulting PVBLG has much narrower 
MWD (Mw/Mn = 1.10, entries 3, Table 5.1), as evidenced by the monomodal GPC curves 
shown in Figure 5.3. The control over the MW of PVBLG was also improved as 
compared to the PVBLG obtained from the polymerization without the addition of NB 
(entry 3 vs. entry 1, Table 5.1). Polymerizations with different amount of NB gave 
PVBLGs with similarly well controlled MWs and narrow MWDs (Figure 5.3), 
suggesting that NB primarily functions as the free radical inhibitor and has no other 
obvious effect on the polymerization. The initial VB-Glu-NCA concentrations do not 
affect the polymerization either at the fixed volume of the polymerization solvent (500-
µL DMF) and NB (30 µL) (Fig. 5.4).  I next tested the polymerization of VB-Glu-NCA 
at selected M/I ratios (20/1, 40/1, 50/1, 70/1 and 100/1) using HMDS as the initiator in 
the presence of NB and found that the obtained MWs were in excellent agreement with 
the expected MWs with MWDs all below 1.2 (Fig. 5.5). As the M/I ratio of 20:1, for 
instance, the Mn value of the PVBLG was 5.33 × 103 g/mol, which is only an 8.8% 
deviation from the calculated MW (4.9 × 103 g/mol). 
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Figure 5.1 X-Ray diffraction image of VB-Glu-NCA  
 
 
Table 5.1  HMDS-Mediated VB-Glu-NCA Polymerization. 
entry monomer M/HMDS/C Cata.a NB
b
(µL)
time 
(h)
conv. 
(%) Mn (Mn
*) (× 10-4) c MWD
1 VB-Glu-NCA 50/1/0 NA 0 30 >98 1.87 (1.22) 2.03
2 Glu-NCA 50/1/0 NA 0 8 >98 1.17 (1.09) 1.15
3 VB-Glu-NCA 50/1/0 NA 30 30 >98 1.43 (1.22) 1.10
4 VB-Glu-NCA 200/1/0.1 NA 30 40 67 3.30 (4.9) 1.08
5 VB-Glu-NCA 200/1/0.1 C1 30 20 >98 3.92 (4.9) 1.21
6 VB-Glu-NCA 200/1/0.1 C2 30 24 >98 4.68 (4.9) 1.08
7 VB-Glu-NCA 200/1/0.5 C3 30 40 90 4.96 (4.9) 1.10
8 Lys-NCA/VB-Glu-NCA
(20/1+50/1)
/0.02d C2 30 8+12
e >98 0.61/2.10(0.52 /1.74) f
1.05/
1.18g
 
aC1 = 1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene (NHC), C2 = 1,5,7-
triazabicyclo[4.4.0]dec-5-ene (TBD), and C3 = 4-(dimethylamino)pyridine (DMAP); bNB = 
nitrobenzene; cObtained MW (expected MW *); dFeeding ratio of (Lys-NCA/HMDS + VB-Glu-
NCA/HMDS)/Cat.;  [e] Lys-NCA polymerization time + VB-Glu-NCA polymerization time; 
fObtained MW of PZLL/PZLL-b-PVBLG (expected MW of PZLL/PZLL-b-PVBLG ); gMWD of 
PZLL/PZLL-b-PVBLG.  
 
73 
 
 
0
0.5
1
1.5
2
2.5
3
3.5
4
0 5 10 15 20 25 30
Glu-NCA
VB-Glu-NCA
time (h)
ln
([M
0]/[
M
])
 
Figure 5.2 Kinetic study of Glu-NCA and VB-Glu-NCA polymerization in DMF at room 
temperature. The initial NCA concentration was 0.2 mM. The conversion of the NCA was 
determined by monitoring the FTIR anhydride band at 1784 cm-1. 
 
 
Mn (× 10-4) MWD
expected 1.22 NA
control 1.87 2.03
NB1 1.21 1.13
NB2 1.11 1.17
NB3 1.43 1.10
NB4 1.41 1.07
20 25 30 35
retention time (min)
control
NB1
NB2
NB3
NB4
 
Figure 5.3 The overlay of GPC (MALLS detector) curves of PVBLG derived from HMDS-
mediated VB-Glu-NCA polymerizations at a M/I ratio of 50:1 in the presence of various amounts 
of NB (control: black, 0 µL; NB1: blue, 10 µL; NB2: orange, 20 µL; NB3: green, 30 µL; NB4: 
red, 40 µL).  The MW and MWD of the resulting PVBLGs were summarized in the table (right 
panel).  
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20 25 30 35
0.2 M
0.4 M
0.4 M
0.5 M
Mn (× 10-3) MWD
expected 12.2 NA
0.2 M NCA 11.2 1.17
0.3 M NCA 11.1 1.12
0.4 M NCA 12.2 1.18
0.5 M NCA 15.7 1.11
 
Figure 5.4  The overlay of the GPC (MALLS detector) curves of PVBLGs derived from HMDS-
mediated VB-Glu-NCA polymerizations at different initial VB-Glu-NCA concentrations at the 
M/I ratio of 50/1 in the mixture of DMF/NB (v/v = 500/30). The MW and MWD of the resulting 
PVBLGs were summarized in the table (right panel). 
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Figure 5.5 Plot of Mn and MWD of HMDS-mediated VB-Glu-NCA polymerization at various 
M/I ratios in the mixture of DMF/NB (v/v = 500/30).  
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5.3.2  Polymerization of VB-Glu-NCA: addition of co-catalysts 
Although PVBLGs with controlled MWs and narrow MWDs can be achieved 
using HMDS/NB mediated polymerization, this polymerization condition cannot be 
conveniently used for the synthesis of high-MW PVBLG due to the low activity of VB-
Glu-NCA. For instance, an HMDS/NB-mediated VB-Glu-NCA polymerization at an M/I 
ratio of 200:1 only gave PVBLG in 67% yield after 40 hours (entry 4, Table 5.1).  To 
solve this problem, I attempted to use a co-catalyst in conjunction with HMDS/NB to 
accelerate the polymerization (Scheme 5.2a). 
 
Our previous study indicated that HMDS-mediated Glu-NCA polymerization 
proceeds via a trimethylsilyl carbamate (TMS-CBM) terminal group.  Polypeptide chains 
were propagated through the transfer of the TMS group from the terminal TMS-CBM to 
the incoming monomer to form a new TMS-CBM terminal propagating group (Scheme 
5.2b). To promote the chain propagation, three co-catalysts, 1,3-bis(2,4,6-
trimethylphenyl)imidazol-2-ylidene  (C1),  1,5,7-triazabicyclo[4.4.0]dec-5-ene (C2), and 
4-(dimethylamino)pyridine (C3), were tested. All these agents are strong nucleophiles of 
acylation and have been previously used as effective organocatalysts for lactide 
polymerization.[16, 51] Here I used them primarily to accelerate the chain propagation by 
either facilitating the TMS transfer to the incoming VB-Glu-NCA monomer by attacking 
the TMS-CBM carbonyl group (Scheme 5.2c)[52] or by activating the incoming VB-Glu-
NCA monomer (Scheme 5.2d).  In the presence of the co-catalysts, the polymerization 
was noticeably faster (entry 5-7 vs. entry 4, Table 5.1). HMDS/NB/C1 mediated the 
fastest polymerization among the three HMDS/NB/co-catalyst systems studied. At a VB-
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Glu-NCA/HMDS/C1 molar ratio of 200:1:0.1, the reaction completed within 20 h with 
quantitative monomer conversion. The GPC analysis of the reaction mixture in situ 
revealed that the resulting PVBLG has an Mn value of 3.92 × 104 g/mol as compared to 
the expected Mn of 4.88 × 104 g/mol and an MWD of 1.21 (entry 5, Table 5.1). The 
presence of C2 also increased the polymerization rate dramatically. At the VB-Glu-
NCA/HMDS/C2 molar ratio of 200:1:0.1, the polymerization completed within 24 h.  
HMDS/NB/C2 outperformed HMDS/NB/C1 with regard to the control over PVBLG MW 
with an Mn value of 4.68 × 104 g/mol and a very narrow MWD (Mw/Mn = 1.08, entry 6, 
Table 5.1). HMDS/NB/C3 mediated polymerization was the slowest among the three 
tested HMDS/co-catalyst systems. The presence of 0.5 equivalent of C3 to HMDS 
resulted in 90% conversion of VB-Glu-NCA for a 40-h polymerization (entry 7, Table 
5.1). Although HMDS/NB/C3 mediated polymerization was slower than C1 and C2, the 
polymerization still showed remarkable control over the MW and yielded PVBLG with 
very narrow MWD (entry 7, Table 5.1).  It is unclear whether C1-3 accelerates the chain 
propagation by facilitating TMS transfer to the incoming NCA monomer or by activating 
the incoming NCA monomer. 
 
Because HMDS/NB/C2 shows overall the best controlled polymerization with 
respect to the kinetics of polymerization and the control over PVBLG MWs and the 
MWDs, I performed additional VB-Glu-NCA polymerization studies using this system.  
As shown in Figure 5.6a, the obtained Mn’s agreed nearly perfectly with the expected 
Mn’s for polymerization carried out at different M/I ratios. The PVBLGs all had very 
narrow MWDs (1.08-1.27). The small error bars indicate the results were highly 
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reproducible. The MWs of PVBLG showed linear correlation with the conversions of 
VB-Glu-NCA and agreed well with the expected MWs (Figure 5.6b), demonstrating that 
PVBLG chains were propagated through living chain ends. Block co-polypeptides, such 
as poly(ε-Cbz-L-lysine)-block-PVBLG (PZLL-b-PVBLG ), can be readily prepared with 
predictable MWs and narrow MWDs (entry 8, Table 5.1). HMDS/NB/C1 and 
HMDS/NB/C3 also showed linear MW growth across the tested VB-Glu-NCA/HMDS 
ratios from 20:1 to 250:1 (see Table 5.2 and 5.3), suggesting that the dual-catalyst 
systems (HMDS/NB/C1-C3) mediate well controlled, living polymerizations of VB-Glu-
NCA. 
 
Scheme 5.2   structure of cocatalysts (a) to promote the polymerization of VB-Glu-NCA and 
proposed chain propagation mechanisms (b-d)  
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Table 5.2  HMDS/C1 mediated VB-Glu-NCA polymerization in the mixture of DMF/NB (v/v = 
500/30) at room temperature. 
entry NCA/HMDS/C time (h) conv. (%) Mn (Mn*) (× 10-3)a MWD
1 20/1/0.04 8 >98 6.25 (4.9) 1.45
2 20/1/0.01 10 >98 5.51 (4.9) 1.30
3 50/1/0.1 10 >98 15.5 (12.2) 1.48
4 50/1/0.025 10 >98 11.9 (12.2) 1.37
5 100/1/0.1 12 >98 22.9 (24.5) 1.31
6 150/1/0.1 18 >98 31.7(36.8) 1.23
7 200/1/0.1 20 >98 39.2 (49) 1.21
 
aMn =MW obtained and Mn* = MW expected 
 
 
Table 5.3  HMDS and C3 mediated VB-Glu-NCA polymerization in the mixture of DMF/NB 
(v/v = 500/30) at room temperature. 
entry NCA/HMDS/C time (h) conv. (%) Mn (Mn*) (× 10-3)a MWD
1 20/1/0.04 12 >98 5.33 (4.9) 1.21
2 50/1/0.1 12 >98 15.5 (12.2) 1.25
3 100/1/0.1 24 90 22.5 (24.5) 1.03
4 150/1/0.1 36 88 33.1(36.8) 1.06
5 200/1/0.5 40 90 49.6 (49) 1.10
 
aMn =MW obtained and Mn* = MW expected 
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Figure 5.6 a) Plot of MW and MWD versus M/I in the HMDS/C2 initiated VB-Glu-NCA 
polymerization; each data point was performed three times and the error bars were presented as 
the standard deviation b) Plot of MW and MWD versus conversion in the HMDS/C2 initiated 
VB-Glu-NCA polymerization. 
 
 
5.3.3 Post-functionalization reactions of PVBLG 
With the successful establishment of ROP of VB-Glu-NCA for the controlled 
synthesis of PVBLG, I next performed all of the post-polymerization reactions as 
proposed and illustrated in Scheme 5.1, aiming to explore the scope and versatility of 
PVBLG for the synthesis of functional polypeptides. The N-terminus of the PVBLG70, a 
70mer of PVBLG, was protected by a CBZ group immediately after the polymerization 
to prevent undesired side reactions.  PVBLG70 was first treated with ozone; the vinyl 
group was converted to alcohol in (PVBLG-a)70 in 72% yield, (route a, Scheme 5.1) and 
aldehyde in (PVBLG-b)70 in 78% yield (route b, Scheme 5.1), when sodium borohydride 
and triphenylphosphine were used as the reductive reagent, respectively. The vinyl group 
of PVBLG70 was also converted to carboxylic acid (PVBLG-c)70 in 81% yield under mild 
condition by osmium tetroxide-promoted catalytic, oxidative cleavage of the olefin (route 
c, Scheme 5.1).[48] 1,2-Bishydroxylation of the vinyl of PVBLG70 was performed by 
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following osmium tetraoxide catalyzed oxidative addition in the presence of N-
methylmorpholine N-oxide (route d, Scheme 5.1), resulting in (PVBLG-d)70 in 79% yield 
that is water-soluble, has very low toxicity (IC50 > 1 mM, Figure 5.7) and adopts helical 
conformation (Figure 5.8). To introduce epoxy group, PVBLG70 was treated with the in 
situ generated dimethyl dioxirane under mild condition to give (PVBLG-e)70 in 69% yield 
(route e, Scheme 5.1). I also performed the metathesis reaction of PVBLG70 (route f, 
Scheme 5.1). By mixing the polymer solution in dichloromethane with excessive cis-1,4-
dichlorobutene in the presence of the second-generation Grubbs catalyst, allyl chloride 
functionalized polypeptide (PVBLG-f)70 was exclusively generated in 78% yield.  By 
treating PVBLG70 with 9-borabicyclo[3.3.1]nonane (9-BBN) followed by 4’-
bromoacetophenone and tetrakis(triphenylphosphine)-palladium, (PVBLG-g)70 was 
derived in 60% yield via the Suzuki reaction (route g, Scheme 5.1).  UV-induced 
crosslinking reaction of the vinyl group of PVBLG70 resulted in formation of an 
organogel(route h, Scheme 5.1)[53]. The efficiencies of post-functionalization reactions 
for the synthesis of PVBLG-a~g were found to be at least 90% as confirmed by the NMR 
analyses. Thus, the post-functionalization of PVBLG can be an extremely useful 
approach to generate a large number of PBLG-like materials with a variety of side chain 
functionalities and/or moieties. 
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Figure 5.7  Cytotoxicity evaluation of (PVBLG-d)70 using MTT assay 
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Figure 5.8 CD curves of PVBLG-d70 at the concentration of 0.05mg/mL (blue) and 0.1mg/mL 
(purple). The CD spectra of both samples showed two minima, one at 208 nm and the other at 
222 nm, indicating the formation of α-helical conformations. The mean residua molar ellipticities 
at both 208 nm and 222 nm of these two samples were identical, suggesting that (PVBLG-d)70 
stayed monomeric at these concentrations in water. 
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5.4 Conclusions 
In conclusion, I report the preparation of polypeptides with PLG backbone and a 
variety of different side chains via controlled polymerization of VB-Glu-NCA followed 
by a variety of highly efficient post-functionalization reactions.  VB-Glu-NCA is readily 
available in large scale with satisfactory purity (purified by recrystallization) for 
polymerization.  The initiator (HMDS) and the co-catalyst (TBD) of the polymerization 
are both commercially available and can be used as received to prepare PVBLGs with 
precisely controlled MWs and narrow MWDs. The side-chain post-functionalization 
reactions are also straightforward. I believe this streamlined strategy will find widespread 
utility for the synthesis of a large number of functional polypeptides with tailored side-
chain structures.    
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CHAPTER 6 
IONIC POLYPEPTIDES WITH UNUSUAL HELICAL STABILITY 
6.1 Introduction 
The α-helix, the most prevalent type of secondary structure found in proteins, 
forms the cornerstone of the three-dimensional architecture of proteins and regulates 
numerous biological activities[1].  As a motif with a unique folding/unfolding property 
and a rigid, rod-like morphology, the α-helix has been the subject of intense study and 
has been broadly used as a building block in the design of therapeutics and molecular 
assemblies[2-12].  Polypeptides bearing an α-helical conformation can be made entirely of 
hydrophobic amino acids with high helical propensities (e.g., Ala and Leu)[13-15].  
However, the usefulness of these structures is limited because of their poor aqueous 
solubility and processability.  In the past, interest has been largely focused on the design 
and synthesis of water-soluble α-helical polypeptides or peptide motifs that usually 
contain a handful of charged amino acids (e.g., Glu or Lys).  Yet, the incorporation of 
charged residues into polypeptides often results in increased side-chain electrostatic 
repulsion[3, 16-18], which tends to destabilise the helical conformation.  In the extreme 
context in which the polypeptides are made exclusively of amino acids bearing charged 
side chains, such as poly(L-glutamate) (PLG) or poly(L-lysine) (PLL), they adopt random 
coil conformations when their side chains are charged.   
As increasing the water solubility by introducing charge groups and enhancing the 
helical stability of polypeptides are often contradictory to each other, it has been a routine 
strategy to integrate both water-soluble and helix-stabilising motifs in the peptide 
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structure to design water-soluble helical peptides.  Often, peptides are designed to have 
the charged amino acid residues placed on one side of the helix surface and the residues 
responsible for stabilising the helix through side-chain hydrophobic interactions[18], salt 
bridges[19], or tethering[20] placed on the opposite side of the helix surface.  These 
strategies require the design of peptides with specific sequences and/or involve tedious 
chemistries of polypeptide side chains that are typically difficult to control.  For 
polypeptides made by polymerisation rather than through step-wise synthesis, the above-
mentioned helix-stabilisation strategies cannot be applied.   
Water-soluble polypeptides that adopt stable α-helical conformations have long 
been sought after.   Tremendous efforts have been focused on introducing neutrally 
charged, hydrophilic functional groups[21] or moieties[22]. For instance, poly(N-
hydroxyalkyl-L-glutamine)[21],  derived from aminolysis of poly(L-glutamate), was found 
to be water-soluble due to its pendant hydroxyl groups.  It adopts moderately high helical 
structure (up to ca. 65% helicity) in aqueous solution[21].  Deming and co-workers 
reported the synthesis of PLL containing pendant oligoethyleneglycol moieties via the 
ring-opening polymerisation of oligoethyleneglycol-containing lysine N-
carboxyanhdyride (NCA).[22]  The resulting oligoethyleneglycol-graft PLL showed 
excellent water-solubility and up to ca. 100% helical structure in pH 7 water at 25 oC.   
These polypeptides were designed in a manner to introduce water-soluble motifs on a α-
helical structure in the absence of electrostatic perturbations.  To our knowledge, charged, 
water-soluble polypeptides that adopt stable α-helical conformations, i.e., α-helical 
polypeptide electrolytes (αHPEs), have never been reported.      
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When analysing helix-forming amino acids, it can be found that Ala and its three 
analogues, α-aminobutyric acid, norvaline and norleucine (Figure 6.1a), have identical 
helical propensities[23], indicating that the linear elongation of an amino acid side chain 
with hydrocarbons does not affect its helix-forming capability.  When a charged group 
(e.g., COO- or NH3+) is placed at the termini of the hydrocarbon side chains of these 
amino acids, however, substantially reduced amino acid helix propensity scales are 
noted[24].  Interestingly, the helix propensity of Asp-, Glu-, Lys+ and Arg+, the four 
charged natural amino acids with straight side chains (Figure  6.1b), is strongly correlated 
with the length of the hydrocarbon side chain; the longer the hydrocarbon side chains (the 
further away the charge is from the backbone), the higher the helix-forming propensity.  
Their helical propensities are in the order of Arg+ > Lys+ > Glu- > Asp-, where the charge 
is 6, 5, 4 or 3 σ-bonds away from the peptide backbone, respectively (Figure  6.1b)[24].  I 
reasoned that the differences in their helix-forming propensities could be due, in part, to 
the differences in charge density on the helical surfaces, with the poly(Arg+) helix being 
the lowest (the largest helical surface area, the weakest electrostatic repulsion) and 
poly(Asp-) being the highest (the smallest helical surface area, the strongest electrostatic 
repulsion) if they are both formed (Figure 6.1c).  I postulated that when the charge is 
moved further away from the peptide backbone to reduce the overall charge density on 
the helical surface and charge repulsion, at some point the charge may have a negligible 
effect on the helical propensity of amino acids with long, straight side chains.  As a result, 
these polypeptides with charges that are distally situated from the peptide backbone on a 
hydrophobic side chain may simultaneously maintain water solubility and stable helical 
structures (Figure 6.1c).   
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Figure 6.1 Amino acids and their helix-forming properties. a, Illustration of amino acids 
containing linear hydrocarbon side chains with variable lengths. b, Illustration of four amino 
acids with charged side chains (Asp, Glu, Lys and Arg) and the correlation of their helix-forming 
propensity with the distance between the side-chain charge and the α-carbon. c, Illustration of 
polypeptides with charged side chains and the postulated helix-random coil transition in response 
to the length of the side chains. 
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6.2 Materials and Methods 
6.2.1 General 
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA) and 
used as received unless otherwise specified. Anhydrous dimethylformamide (DMF) was 
dried by two columns packed with 4Å molecular sieves and stored in a glove box.  
Tetrahydrofuran (THF) and hexane were dried by a column packed with alumina and 
stored in a glove box. Anhydrous CDCl3 was prepared by treating the purchased CDCl3 
with CaSO4 overnight, followed by distillation under nitrogen. The purified CDCl3 was 
stored in the presence of 4Å MS.  Dry nitrobenzene and DMSO-d6 were prepared by 
treating regular nitrobenzene and DMSO-d6 with CaH2 followed by distillation under 
reduced pressure. H-Lys(Z)-OH and H-Glu(OBn)-OH were obtained from Chem-Impex 
International (Des Plaines, IL, USA) and used as received. Glu-NCA and Lys-NCA were 
prepared by following the previously reported procedures[25].       
     
NMR spectra were recorded on a Varian UI400 MHz, a UI500NB MHz or a 
VXR-500 MHz spectrometer.  Tandem gel permeation chromatography (GPC) 
experiments were performed on a system equipped with an isocratic pump (Model 1100, 
Agilent Technology, Santa Clara, CA, USA), a DAWN HELEOS 18-angle laser light 
scattering detector (also known as multi-angle laser light scattering (MALLS) detector, 
Wyatt Technology, Santa Barbara, CA, USA) and an Optilab rEX refractive index 
detector (Wyatt Technology, Santa Barbara, CA, USA). The detection wavelength of 
HELEOS was set at 658 nm.  Separations were performed using serially connected size 
exclusion columns (100 Å, 500 Å, 103Å and 104 Å Phenogel columns, 5 µm, 300 × 7.8 
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mm, Phenomenex, Torrance, CA, USA) at 60°C using DMF containing 0.1 M LiBr as the 
mobile phase. The MALLS detector is calibrated using pure toluene with no need for 
calibration using polymer standards and can be used for the determination of the absolute 
molecular weights (MWs). The MWs of polymers were determined based on the dn/dc 
value of each polymer sample calculated offline by using the internal calibration system 
processed by the ASTRA V software (version 5.1.7.3, Wyatt Technology, Santa Barbara, 
CA, USA).  Infrared spectra were recorded on a Perkin Elmer 100 serial FTIR 
spectrophotometer calibrated with polystyrene film. Circular dichroism (CD) 
measurements were carried out on a JASCO J-700 or a JASCO 720 CD spectrometer. 
Ozone was produced by an OZV-8S ozone generator manufactured by Ozone Solutions 
Inc (Hull, IA, USA). Lyophilization was performed on a FreeZone lyophilizer (Labconco, 
Kansas City, MO, USA).  
 
6.2.2 Synthesis of PAHG, PAPG, PAPTG, PAEG, PAHEG, and PLL (Figure 6.2a) 
6.2.2.1 Synthesis of poly(γ-(6-aminohexyl)-L-glutamate)) (PAHG) 
Synthesis of Poly(L-Glutamic Acid) PLG57 Poly(γ-benzyl-L-glutamate) (PBLG) with a 
degree of polymerization of 57 (PBLG57) was synthesized by following the procedure 
previously reported[25]. The Mn is 12,500 g/mol and PDI (Mw/Mn) is 1.15 as characterized 
by gel permeation chromatograph (GPC).  The deprotection of PBLG57 was performed at 
0oC to give PLG57 in quantitative yield by following a slightly modified, standard 
procedure[26-28].  The resulting polymer (500 mg) was treated with 2 M NaOH (10 mL) 
and then with CBZ-Cl (0.1 mL) for 16 h to protect the N-terminus of PLG with CBZ. The 
resulting PLG was acidified by 3 M HCl. The precipitates were purified subsequently by 
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dialysis against DI water followed by lyophilisation. 1H NMR (TFA-d, 500 MHz): δ 4.86 
(1H, αH), 2,68 (2H, γH), 2.34 (1H , βH) and 2.19 (1H, βH).   
 
Synthesis of 6-(N-Boc-Amino)-1-Hexanol   6-Amino-1-hexanol (1.17 g, 10 mmol) was 
dissolved in chloroform (15 mL) and stirred in an ice bath. (Boc)2O (2.25 g, 10.8 mmol) 
was added to the mixture in a small portion for about 5 min.  The reaction mixture was 
stirred in the ice bath for another 2 hours before the solvent was removed under vacuum. 
The crude product was recrystallized with hexane to give pure 6-(N-Boc amino)-1-
hexanol (1.95 g, 90% yield).  1H NMR (CDCl3, 500 MHz): δ 4.58 (s, 1H, NH), 3.62 (t, 
2H, J =8.0 Hz, -CH2CH2CH2CH2OH), 3.15 (t, 2H, J =7.5 Hz, BocNHCH2CH2), 1.77 (S, 
1H, -CH2CH2CH2CH2OH), 1.60-1.30 (m, 17H, 
(CH3)3C(CO)NHCH2CH2CH2CH2CH2CH2OH). 13C NMR (CDCl3, 500 MHz): δ 156.0, 
79.0, 62.6, 40.3, 32.5, 30.2, 28.4, 26.3, 25.2.   
 
Synthesis of PAHG PLG57 (25 mg, 0.20 mmol Glu repeating unit), BOP-Cl (350 mg, 
1.37 mmol), DMAP (17 mg, 0.14 mmol), anhydrous triethylamine (0.2 mL, 1.4 mmol) 
and 6-(N-Boc amino)-1-hexanol (440 mg, 2 mmol) were added in anhydrous N-
methylpyrrolidone (NMP, 4 mL) under nitrogen in an ice bath. The conjugation reaction 
was allowed to proceed at 40-50oC for 3 days. Ethyl acetate (30 mL) and a brine solution 
(20 mL) were added to the reaction mixture. The organic phase was washed by NaHCO3 
(1M, 10 mL) and DI water (2 × 15 mL), dried with Na2SO4, and concentrated under 
vacuum. An oily residue was yielded, which was washed by ether (3 × 10 mL) to remove 
the excess 6-(N-Boc)-1-hexanol. The residue was dissolved in chloroform; TFA was 
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added to the solution at room temperature. The mixture was stirred overnight, 
concentrated under vacuum to yield the deprotected crude product PAHG57.  PAHG57 was 
then dissolved in 3M HCl, dialyzed in DI water and lyophilized (22 mg, 43% overall 
yield). The grafting efficiency was 95% as calculated from 1H NMR spectrum.  
 
6.2.2.2  Synthesis of poly(γ-(3-aminopropyl)-L-glutamate) (PAPG)                PAPG57 was 
synthesized through conjugation of 3-(N-Boc-amino)propanol to PLG57 followed by 
deprotection, following the same protocol for the synthesis of PAHG (18 mg; 48% 
overall yield). The grafting efficiency was above 95%, as calculated from 1H NMR.  
 
6.2.2.3  Synthesis of poly(γ-(5-aminopentanyl)-L-glutamate) (PAPTG50)  PAPTG50 was 
synthesized through conjugation of 5-(N-Boc-amino)pentanol to PLG57 followed by 
deprotection, following the same protocol for the synthesis of PAHG (5 mg, 38% yield). 
The grafting efficiency was above 90%, as calculated from 1H NMR. 
 
6.2.2.4 Synthesis of poly(γ-((2-aminoethyl)ethyleneglycol)-L-glutamate) (PAEG50)  
PAEG50 was synthesized through conjugation of 2-(2’-(N-Boc)aminoethoxy)ethanol to 
PLG57 followed by deprotection, following the same protocol for the synthesis of PAHG 
(8 mg, 46% overall yield) The grafting efficiency was above 90%, as calculated from 1H 
NMR. 
 
6.2.2.5 Synthesis of poly(γ-((2-aminoethyl)-heptaethyleneglycol)-L-glutamate) (PAHEG50)  
PLG50 (15 mg, 0.12 mmol) was dissolved in dry NMP (5 mL) under nitrogen. The 
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solution was cooled in an ice bathe. O-(2-Azidoethyl)heptaethylene glycol (250 mg, 0.75 
mmol), DMAP (150 mg, 1.23 mmol), BOP-Cl (175 mg, 0.7 mmol) and 
diisopropylethylamine (0.1 mL, 1.0 mmol) were added to stirred solution under nitrogen.  
The ice bath was removed after the mixture was stirred for 20 min and the solution was 
stirred for an additional 6 h at room temperature followed by another 4-day reaction at 
45oC.  The mixture was dialysed (MWCO = 8,000 Da) against DI water for 24h to 
remove unreacted reagents. After lyophilization, the residue was dissolved in chloroform 
(3 mL) containing triphenylphosphine (80 mg, 0.3 mmol). The mixture was stirred for 2h 
at room temperature followed by the removal of the solvent under vacuum. DI water (10 
mL) was added to the mixture and then the solution was filtered by regular filter paper. 
The filtrate was treated by ammonium hydroxyide (10 µL) for 4h, dialyzed in DI water 
and lyophilized to yield (PAHEG)57 (18 mg, 23 % overall yield). The grafting efficiency 
was 90% as calculated from the 1H NMR spectrum of (PAHEG)57. 
 
6.2.2.6 Synthesis of a 75mer of poly(L-Lys) (PLL)75  Poly(ε-CBZ-L-lysine) (PZLL) was 
prepared at a monomer/initiator ratio of 75 by following literature reported procedure[25]. 
The Mn and PDI of the PZLL were 20.7 kg/mol and 1.05, respectively.  The deprotection 
of PZLL was performed by following the standard procedure published previously[29] to 
give the desired PLL75. 
 
6.2.3    Synthesis of PVBLG-X (X = 1-7) (Figure 6.2b and 6.2c) 
6.2.3.1 Synthesis of γ-(4-Vinylbenzyl)-L-Glutamate NCA (VB-Glu-NCA)  the protocol for 
synthesis of VB-Glu-NCA can be found in Chapter 5. 
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6.2.3.2 General Procedure for the Polymerization of VB-Glu-NCA    the protocol for 
polymerizaion of VB-Glu-NCA can be found in Chapter 5. 
 
6.2.3.3 Synthesis of Poly(γ-(4-aldehydebenzyl)-L-glutamate) (PABLG)    PVBLG (10 mg) 
was dissolved in chloroform (10 mL) at -78 oC. O2 was bubbled into the solution for 1 
min followed by bubbling of O3 until the solution became blue. O3 was then replaced by 
O2, which was bubbled into the solution for another 2 min until the solution became 
colourless. The solution was then degassed and back filled with nitrogen. Ph3P (26 mg) 
was then added to the mixture. The solution was stirred at room temperature for 2-3 h. 
The solvent was then removed under vacuum.  The resulting poly(γ-(4-aldehydebenzyl)-
L-glutamate) (PABLG) was purified by sonicating the polymer in methanol (3 × 15 mL) 
to remove the unreacted Ph3P and other impurities.  1H NMR (TFA-d, 500 MHz): δ 10.31 
(1H, CHOC6H4), 8.40 (d, 2H, J =7.0 Hz, ArH), 7.96 (d, 2H, J =7.0 Hz, ArH), 5.71 (2H, 
CHOC6H4CH2), 5.21 (1H, CHCH2CH2CO2CH2), 3.12 (2H, CHCH2CH2), 2.75 (1H, 
CHCH2CH2), 2.56 (1H, CHCH2CH2).  
 
6.2.3.4  Synthesis of PVBLG-X (X = 1-7)  The poly(γ-(4-aldehydebenzyl-L-glutamate) 
(20 mg), amine (3-5 molar equiv. relative to the Glu repeating unit) and the reducing 
reagent (5-10 molar equiv.) (Table 6.1) were mixed in THF (3 mL) (except for 7 with 
DMF was used as the solvent).  The reaction mixtures were stirred at 50-60oC for 24-72 h 
(Table 6.1). The mixture was then poured into 3 M HCl (3 mL) followed by dialysis 
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against water and lyophilization. The yields of the products PVBLG-X (X = 1-7) were 
around 50-75% after dialysis. The grafting efficiencies were analysed by 1H NMR. 
6.2.4   General procedure for the analysis of polypeptide conformations by CD 
The CD experiments were performed on a JASCO J-700 or a JASCO J-720 CD 
spectrometer.  The polypeptide samples were generally prepared at concentrations of 
0.01-0.1 mg/mL at pH 3 unless otherwise specified. The solution was placed in a quartz 
cell with a pathlength of 0.2 cm. The mean residue molar ellipticity of each polymer was 
calculated based on the measured apparent ellipticity by following the literature reported 
formulas: Ellipticity ([θ] in deg·cm2·dmol-1) = (millidegrees × mean residue 
weight)/(pathlength in millimeters × concentration of polypeptide in mg ml-1)[30-31].   For 
the temperature-dependent experiments, the temperature of the sample chamber (where 
the quartz cell was placed) was controlled by a water bath (from 4 oC to 70 oC).   The 
samples were equilibrated at the corresponding temperature for at least 10 min before the 
CD measurements. By following similar preparation method, the polymers were 
dissolved in DI water or in a solution containing NaCl, urea or methanesulfonic acid 
(MSA). For the pH-dependent experiments, the pH of the polymer solution was tuned by 
the addition of a concentrated HCl or NaOH solution.  The -helix contents of the 
polypeptides were calculated by following equation:  % -helix = (-[θ222] + 
3000)/39,000[32].  
 
6.2.5  Hydrolysis kinetics of the benzyl ester of PVBLG-1    
PBS (100 µL, 10 ×) was lyophilized and followed by addition of D 2O (1 mL) to 
prepare a PBS/D2O (1 ×) solution.  (PVBLG-1)40 (10 mg) was dissolved in this 1 × 
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PBS/D2O solution and incubated at room temperature. The hydrolysis of the benzyl ester 
was monitored by 1H NMR.  
 
6.2.6 Wide-angle X-ray diffraction of PVBLG-1  
Two-dimensional (2D) wide-angle x-ray diffraction (WAXD) experiments were 
performed on an Oxford Xcalibur diffractometer with an ONYX CCD area detector. The 
X-ray wavelength was 0.1542 nm for Cu Kα. One-dimensional (1D) profiles were 
obtained by integration from corresponding 2D WAXD images. The d-spacing was 
calibrated using silver behenate which has the first-order reflection (d001 = 58.380 Å) at q 
= 1.076 nm-1 (scattering vector q = (4pisinθ)/λ with  being half of the scattering angle). 
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Figure 6.2 | Synthesis of polypeptides with charged side chains. a, Synthesis of PAPG, 
PAPTG, PAHG, PAEG  and PAHEG. The brief protocol of each step was listed below: i. 
Hexamethyldisilazane (HMDS)/DMF; ii. CBZ-Cl; iii. HBr; iv. OH-R-NH(Boc), BOP-Cl; v. HCl; 
vi. OH-R-N3, BOP-Cl; vii. 1. PPh3, CHCl3; 2. NH3-H2O. b, Synthesis of PVBLG-X. The brief 
protocol of each step was listed below: i. phosgene; ii. HMDS/DMF/nitrobenzene; iii. Bzenyl 
chloroformate/diisopropyl ethyl amine (DIPEA)/tetrabutylammonium floride (TBAF); iv. 
O3/CHCl3/-78 oC; v. X (=R-NH2)/[H]; vi. HCl. c, structures of the X used in the syntehsis of 
PVBLG-X  (X = 1∼7). 
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6.3 Results and Discussion 
6.3.1 Synthesis and conformation analysis of poly(L-glutamates) containing long, side 
chains with pendant amine terminal group  
To test the hypothesis, I prepared a 57mer of poly(γ-(3-aminopropyl)-L-glutamate) 
(PAPG57), a 50mer of poly(γ-(5-aminopentanyl)-L-glutamate) (PAPTG50), and a 57mer of 
poly(γ-(5-aminohexyl)-L-glutamate) (PAHG57) through the ring-opening polymerisations 
(ROPs) of γ-benzyl-L-glutamate N-carboxyanhydride (Glu-NCA)[25, 33-34] followed by 
grafting the corresponding amino alcohol to the pendant carboxylate groups of PLG via 
the formation of ester bonds (Figure 6.2a).  PAPG57, PAPTG50 and PAHG57 contain 
hydrophobic side chains with different lengths and a terminal, charged amine group (-
NH3+) situated 8, 10 and 11 σ-bonds, respectively, away from its backbone.   Compared 
to the circular dichroism (CD) spectrum of a 75mer of poly(L-lysine) (PLL75) at pH 3, 
which is known to adopt a random coil conformation, the CD spectrum of  PAPG57 at pH 
3 showed some characteristics of an α-helical conformation (Figure 6.3a).   A minimum 
at 222 nm with a molar ellipticity ([θ]222) value of -3,100 cm2⋅deg⋅dmol-1 was observed, 
which corresponds to ca. 16% of helical content[32]; the other expected minimum around 
208 nm was not obvious. The characteristic double minimums of the CD spectrum of an 
α-helical conformation became more obvious in PAPTG50 with its helical content at pH 3 
increased to 29% with a [θ]222 value of -7,400 cm2⋅deg⋅dmol-1.  For PAHG57 that has the 
largest space between the charged, terminal amine group and the polypeptide backbone, it 
adopts an α-helical conformation as shown in its CD spectrum with characteristic two 
minimums at 222 nm and 208 nm and has a helical content of 45%.  Apparently, the 
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hypothesis of creating water-soluble, charged, helical polypeptides by placing charges 
distally situated from the peptide backbone is demonstrated to be correct.  
 
PAHG57 showed remarkable pH-independent helical stability at pH values ranging 
from 1 to 10, with -[θ]222 value at 14,000 cm2⋅deg⋅dmol-1 for pH 1 and at 14,200 
cm2⋅deg⋅dmol-1  for pH 10 (≈ 44-45% helical content) (Figure 6.3b).  Further increases in 
pH (pH > 11) resulted in deprotonation of the positively charged amino group on the side 
chain and a decreased solubility of PAHG57.  PAHG57 also showed a lack of 
concentration dependence of its -[θ]222 and -[θ]208 values in helix-forming conditions, 
suggesting that it remains monomeric in solution (Figure 6.3c).  PAHG57 showed 
temperature-dependent helical stability as its -[θ]222 value decreased 45% from 15,900 
cm2⋅deg⋅dmol-1 at 4oC to 8,700 cm2⋅deg⋅dmol-1 at 70oC (Figure 6.3d).  It exhibited 
remarkable stability against changes in the NaCl concentration and remained nearly 
unchanged in its -[θ]222 value when the NaCl concentration was increased from 0 to 4.68 
M at pH 3 at 25°C, a concentration for which all of the charges should have been 
screened, which is distinctly different from PLL75 (Figure 6.3e).  These experiments 
further demonstrate that the surface charges of PAHG50 have minimal effects on its 
helical stability.  The helical conformation of PAHG57 was gradually disrupted at 
increased concentrations of strong denaturing reagents such as urea (Figure 6.3f).   
 
To elucidate the effect of the side chain hydrophobicity and the charge on the 
formation and stabilisation of α-helical conformations, I synthesized a 50mer of poly(γ-
(2-aminoethyl)-ethyleneglycol)-L-glutamate)) (PAEG50) (Figure 6.2a).  PAEG50 has 
100 
 
exactly the same structure as PAPTG50 except that one “CH2” unit of PAPTG50 was 
replaced by an “O” in PAEG50, which makes PAEG more hydrophilic than PAPTG.   The 
CD analysis showed that PAEG50 adopts a random coil structure at pH 3 when the 
terminal amine is protonated (Figure 6.3a), which underscores the importance of the 
hydrophobicity of the side chains connecting the terminal charge and the backbone on the 
stabilisation of the α-helical conformation.  Interestingly, when the side chain of PAEG50 
was elongated by inserting a hydrophilic, hepta(ethylene glycol) to further extend the 
charged amine group, a random coil-to-helix transition was observed and the resulting 
poly(γ-(2-aminoethyl)-heptaethyleneglycol)-L-glutamate)) (PAHEG50) adopts a α-helical 
conformation at pH 3.  These experiments suggest that the reducing helical surface 
charge density (reducing side chain charge repulsion) is crucial to the stabilisation of α-
helical conformation.  
 
6.3.2 Design and synthesis of PVBLG via ring-opening polymerizations of VB-Glu-
NCAs and their conformation analysis.   
Motivated by this discovery, I next tested whether this helix-stabilisation strategy 
could be generally applied to designing water-soluble, α-helical polypeptide electrolytes 
(αHPEs) that contain charged secondary amines with various functional moieties 
attached to the amine. To avoid the harsh deprotection chemistry and low conjugation 
activity illustrated in Figure 6.2a, I attempted and successfully developed a highly 
efficient conjugation strategy that involves the ring-opening polymerisation of γ-(4-
vinylbenzyl)-L-glutamate NCA (VB-Glu-NCA) to yield poly(γ-(4-vinylbenzyl)-L-
glutamate) (PVBLG) followed by the formation of poly(γ-(4-aldehydebenzyl-L-
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glutamate) (PABLG) through the ozonolysis of PVBLG, and hydroamination of the 
PABLG with 6-amino-1-hexanol (1), to give the desired products (PVBLG-1)m, where 
“m” corresponds to the degree of VB-Glu-NCA polymerisation (Figure 6.2b). The 
positive charge of (PVBLG-1)m was placed exactly 11 σ-bonds away from its backbone, 
just like PAHG (The synthesis and controlled polymerization of VB-Glu-NCA were 
reported in Chapter 5). PVBLGs are very soluble in common organic solvents (e.g., THF, 
CHCl3 and DMF), which facilitates their side-chain modification to yield (PVBLG-1)m 
with over 95 % grafting efficiency (entries 1-4, Table 6.1). 
 
(PVBLG-1)60 is highly water-soluble at pH 1-10 (> 40 mg/ml) and adopts an α-
helical conformation with a -[θ]222 value of 32,600 cm2⋅deg⋅dmol-1 for pH values as low 
as 1 (Figure 6.3g), corresponding to a remarkable 91% helical content[32].  The high 
helical content of (PVBLG-1)60 as compared to PAHG57 is presumably due to its 
increased side-chain hydrophobic interactions and possibly the increased structure 
rigidity.  The -[θ]222 value of (PVBLG-1)60 remained unchanged when the solution’s pH 
was increased from 1 to 10 (Figure 6.3b).  At further increased pH values, (PVBLG-1)60 
became less soluble due to deprotonation of its charged secondary amine group.  As with 
PAHG57, (PVBLG-1)60 showed a lack of concentration dependence of its -[θ]222 and -
[θ]208 values in helix-forming conditions, suggesting that it remains monomeric in 
solution (Figure 6.3c).  It has excellent helical stability against elevated temperatures, 
with its -[θ]222 value decreasing 21 % from 31,700 cm2⋅deg⋅dmol-1 at 4 oC to 25,100 
cm2⋅deg⋅dmol-1 at 70 oC (Figure 6.3d), and against helix-destabilising conditions such as 
high concentrations of NaCl (Figure 6.3e), urea (Figure 6.3f) and methanesolfonic acid 
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(MSA) (Figure 6.3h).  PVBLG-1 has unprecedented helical stability against any known 
α-peptides and can maintain 76 % and 58 % of its original helical contents in 6 M urea 
and 69 % MSA, respectively.  The -[θ]222 value of low-MW PVBLG-1’s (below 60mer) 
is strongly correlated with the length of the polymer, and is gradually plateaued at around 
32,000~33,000 cm2⋅deg⋅dmol-1 ( > 90 % ca. helical contents) for PVBLG-1’s with MWs 
beyond 60mer (Table 6.1 and Figure 6.4).  (PVBLG-1)142 predominantly adopts an α-
helical conformation with 100 % helical content, while (PVBLG-1)10 has mixed 
conformations containing both α-helices and β-sheets in solid state (Figure 6.3i). 
Preliminary X-ray scattering experiments showed that PAHG57 and (PVBLG-1)180 
directly cast from water adopted ordered structures with well-defined packing of the 
helical chains. The ordering of helical cylinders is more pronounced in PVBLG-1 than in 
PAHG, evidenced by the numerous reflections in Figure 6.6. A broad and intense 
scattering, comprising the reflections associated with the pitch length of the α-helix, 
appears at 5.2~5.4 Å d-spacing in both figures. PVBLG-1 also showed good stability in 
PBS against ester-bond hydrolysis (Figure 6.5). 
 
I exploited this strategy for the synthesis of PVBLG αHPEs with various other 
motifs on the helix surface.  Amine-containing alcohols (1-amino-2-butanol (2) and 3-
amino-1,2-dipropanol (3)), pyridines (4-(aminomethyl)pyridine (4) and nicotinic 
hydrazide (5)), a crown ether (4-aminobenzo-18-crown-6 (6)) and a carbohydrate (D-
glucosamine (7)) were selected to make the corresponding PVBLG-X (X = 2-7) αHPEs.  
The grafting efficiencies for all of the PVBLG-Xs are excellent (>95%), except for 
(PVBLG-7)40,which has a grafting efficiency of 70% presumably due to the increased 
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steric bulk of the carbohydrate molecules (Table 6.1).  All of the PVBLG-Xs are water-
soluble and adopt α-helical conformations with minima at 208 and 222 nm for their CD 
spectra (Figure 6.3g).  Interestingly, (PVBLG-4)40, (PVBLG-6)44 and (PVBLG-7)40  
showed comparable or even larger –[θ]222 values and helical contents as compared to 
(PVBLG-1)40,  confirming our hypothesis that the physicochemical properties and size of 
the moieties attached to the amine situated distally from the polypeptide backbone have 
negligible effects on the helical stability of the αHPEs.  PVBLG αHPEs containing 
pyridine, crown ether or sugar on the side chain all adopt very stable helical structures in 
water, demonstrating the robustness of this strategy in generating water-soluble rod-like 
αHPEs.  PVBLG-2~7
 
also showed a helical stability similar to that of PVBLG-1
 
against 
changes in the pH, temperature and salt and in the presence of denaturing reagents, as 
exemplified by (PVBLG-7)40, which showed remarkable stability at various pH values 
and temperatures.  
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Figure 6.3 | Characterisation of charged polypeptides. PAHG and PVBLG-X, polypeptides with 
long, charged, hydrophobic side chains, adopt very stable α-helical conformations at low pH, at 
elevated temperature, or in solution containing high concentration of salt or denaturing agents 
(e.g., urea or MSA).  a, CD spectra of various polypeptides bearing charged side chains (PAPG, 
PAPTG, PAHG, PAEG and PAHEG) in aqueous solution at pH = 3. The mean residue molar 
ellipticity was calcualted by following a liturate reported formulas: Ellipticity ([θ]222nm in 
deg·cm2·dmol-1) = (millidegrees × mean residue weight)/(pathlength in millimeters × 
concentration of polypeptide in mg·ml-1)[30-31].  b, The pH dependence of the residue molar 
ellipticity at 222 nm for (PAHG)57, (PVBLG-1)60, (PVBLG-6)44, (PVBLG-7)40 and (PLL)75. c, 
Concentration dependence of residue molar ellipticity at 222 nm for (PAHG)57 and (PVBLG-1)60 
at pH 3. d, Temperature dependence of residue molar ellipticity at 222 nm for (PAHG)57 and 
(PBVLG-1)60 at pH 3. e, Salt concentration dependence of residue ellipticity at 222 nm for 
 PAHG
 PVBLG-1
0.0 0.5 1.0 1.5 2.0 2.5
0
10
20
30
 
-
[ θ
 
] 22
2n
m
 
(10
-
3  
de
g 
cm
2 /d
m
o
l)
 
 
Concentration (mg/ml) 
 PAHG
 PVBLG-1
0 10 20 30 40 50 60 70 80
0
10
20
30
-
[ θ
 
] 22
2n
m
 
(10
-
3  
de
g 
cm
2 /d
m
o
l)
 Temperature (oC)
 
 
a b c
d e f
200 220 240 260
-40
-20
0
20
40
 
 
λ (nm)
[ θ
 
] (1
0-
3  
de
g 
cm
2 /d
m
o
l) MSA/H2O (V/V)
 0/100
 69/31
 82/18
 90/10
PVBLG-1
h ig
 PAHG
 PVBLG-1
 PVBLG-6
 PVBLG-7
 PLL
0 2 4 6 8 10
0
10
20
30
 
-
[ θ
 
] 22
2n
m
 
(10
-
3  
de
g 
cm
2 /d
m
o
l)
 
 
pH
0 1 2 3
0
10
20
30
 PAHG
 PVBLG-1
 PLL
-
[ θ
 
] 22
2n
m
 
(10
-
3  
de
g 
cm
2 /d
m
o
l)
 
 
NaCl (M)
0 1 2 3 4 5 6
0
10
20
30
 PAHG
 PVBLG-1
 PLL
-
[ θ
 
] 22
2n
m
 
(10
-
3  
de
g 
cm
2 /d
m
o
l)
 
 
Urea (M)
200 210 220 230 240 250
-80
-60
-40
-20
0
20
40
[ θ
 
] (1
0-
3  
de
g 
cm
2 /d
m
o
l)
λ (nm)
 
 
PVBLG-1
PVBLG-6
PVBLG-7[ θ
 
] (1
0-
3  
de
g 
cm
2 /d
m
o
l)
 
200 210 220 230 240 250
-30
-20
-10
0
10
[ θ
 
] (1
0-
3  
de
g 
cm
2 /d
m
o
l)
λ (nm)
 
PAHG
PAEG
PAPTG
PAHEG
PLL
PAPG
[ θ
 
] (1
0-
3  
de
g 
cm
2 /d
m
o
l)
1651 cm-1 1545 cm-1
1627 cm-1 1520 cm-1
1651 cm-1
1545 cm-1
16001700
ν (cm-1)
14001500
(PVBLG-1)10
(PVBLG-1)267
105 
 
(Figure 6.3 continued) (PAHG)57 and (PVBLG-1)60 at pH 3 and (PLL)75 at pH 10. f, The helical 
stabilities of (PAHG)57 and (PVBLG-1)60 at pH 3 and (PLL)75 at pH 10 in the presence of urea. g, 
CD spectra of (PVBLG-1)60, (PVBLG-6)44 and (PVBLG-7)40. h, CD spectra of (PVBLG-1)60 in a 
mixed solvent of MSA and H2O. i, FTIR spectra of (PVBLG-1)10 and (PVBLG-1)267. Infrared 
spectra were recorded on a Perkin Elmer 100 serial FTIR spectrophotometer equipped with 
universal attenuated total reflectance (ATR), which enabled the analysis of PVBLG in powder 
form.  (PVBLG-1)10 and (PVBLG-1)267 were purified by dialysis and lyophilized. The fluffy 
samples were placed on the crystal of the sampling accessory for ATR analysis. 
 
 
Table 6.1.  Synthesis and Conformation Analysis of PVBLG-X (X = 1~7) 
 
entry PABLG X        (molar eq.)
Reducing Reagent (molar 
equiv.)/Rec. Time (h)/Temp (oC)
Product 
(PVBLG-X)
Grafting 
Eff. (%)
-[θ ]222 ×10-3 
(cm2⋅deg⋅dmol-1)
Helical 
Content (%)b
1 PABLG10 1 ( 3 ) NaBH(OAc)3 (5)/24/50 (PVBLG-1)10 >95 7.2 26.2
2 PABLG40 1 ( 3 ) NaBH(OAc)3 (5)/24/50 (PVBLG-1)40 >95 23.1 66.9
3 PABLG60 1 ( 3 ) NaBH(OAc)3 (5)/24/50 (PVBLG-1)60 >95 32.6 91.0
4 PABLG150 1 ( 3 ) NaBH(OAc)3 (5)/24/50 (PVBLG-1)150 >95 31.6 88.7
5 PABLG180 1 ( 3 ) NaBH(OAc)3 (5)/24/50 (PVBLG-1)180 >95 32.9 92.1
6 PABLG267 1 ( 3 ) NaBH(OAc)3 (5)/24/50 (PVBLG-1)267 >95 32.8 91.8
5 PABLG45 2 ( 3 ) NaBH(OAc)3 (5)/24/50 (PVBLG-2)45 >95 26.5 75.6
6 PABLG45 3 ( 3 ) NaBH(OAc)3 (5)/24/50 (PVBLG-3)45 >95 19.7 58.2
7 PABLG40 4 ( 5 ) NaBH(OAc)3 (7)/36/50 (PVBLG-4)40 >95 23.1 66.9
8 PABLG40 5 ( 3 ) NaBH(OAc)3 (5)/24/50 (PVBLG-5)40 >95 21.4 62.6
9 PABLG20 6 ( 5 ) NaBH4 (5)/72/(60-40)a (PVBLG-6)20 >95 25.3 72.6
10 PABLG44 6 ( 5 ) NaBH4 (5)/72/(60-40)a (PVBLG-6)44 >95 33.2 92.8
11 PABLG40 7 ( 10 ) NaBH4 (5)/72/(60-40)a (PVBLG-7)40 70 27.2 77.4
 
aPABLG was first condensed with the corresponding amine at 60oC for 48h followed by addition 
of NaBH4; the mixture was stirred at 40oC for 24h.  The mean residue ellipticity [θ] was 
determined by following the liturature reported formulas: Ellipticity ([θ] in deg·cm2·dmol-1) = 
(millidegrees × mean residue weight)/(pathlength in millimeters × concentration of polypeptide in 
mg/ml)[30-31].   
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Figure 6.4  The overlay of the CD spectra of PVBLG-1
 
at pH =3 (left) and the plot of the –[θ]222 
of (PVBLG-1)n versus of the degree of polymerization (n).    
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Figure 6.5  Hydrolysis of (PVBLG-1)40 in PBS (1 ×) at room temperature. 
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Figure 6.6 Wide-angle X-ray Scattering pattern of PAHG (a) and (PVBLG-1)180 (b). 
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6.4 Conclusions 
In conclusion, I discovered that the length of the charged polypeptide side chains 
plays a pivotal role in the stability of the α-helical structures of polypeptide.  When the 
side chains become sufficiently long and the charge groups are placed distally from the 
polypeptide backbone, the substantially reduced charge density on the helix surface 
causes the charge repulsion force to no longer be dominating and helix-disrupting.   Our 
study indicated that polypeptides containing both hydrophobic and hydrophilic side 
chains with distally situated terminal charge groups can adopt helical conformations, but 
only polypeptides with long hydrophobic side chains show high helical contents. For 
polypeptide electrolytes with sufficiently long hydrophobic side chains (substantially 
reduced side-chain charge repulsion forces), side-chain hydrophobic interactions 
dominate to drive the formation of water-soluble, helical structures with remarkable 
helical stability despite changes in the pH or temperature and against various strong 
denaturing reagents. Our discovery may also explain why nature has not evolved to use 
amino acids with long charged side chains as the building blocks for constructing 
proteins. As the reversibility of α-helix folding/unfolding is critical to many important 
biological processes, the incorporation of amino acid residues bearing long, charged, 
hydrophobic side chains would have made the α-helix structure too stable to unfold.  The 
simple polymerization method I have developed for producing helical, water-soluble 
polypeptides (PVBLG-X) bearing various moieties should find various biological and 
biomedical applications. I also believe that the strategy of reducing helical surface charge 
density by incorporating amino acids with elongated, charged side chains can be 
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generally applied to the design of sequence specific peptides with highly stable helical 
conformations. 
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CHAPTER 7 
POLYPEPTIDES BASED GENE DELIVERY 
7.1 Introduction 
Polypeptides were some of the first materials considered for use as non-viral gene 
delivery vectors.  With its ability to bind and condense anionic plasmid DNA, cationic 
poly-L-lysine (PLL) was one of the most well studied of the early gene delivery 
polypeptides.[1,2]  Unfortunately, as a DNA delivery vector, PLL suffered from low 
efficiency and was soon replaced in many basic gene delivery studies by more efficient 
materials like the synthetic polymer polyethylenimine (PEI).[3]  Subsequently, the 
function of peptide-based materials in gene delivery shifted to that of a support role.  For 
example, through covalent conjugation to existing vectors, peptides found use as 
bioactive agents capable of adding cell targeting[4,5], nuclear localization[6-8] or membrane 
destabilization[9] functionality to existing gene delivery materials.  Membrane 
destabilization, in particular, has been a large area for peptide use in non-viral gene 
delivery systems.  The cell penetrating peptides (CPPs) penetratin[10,11], transportan[12,13], 
melittin[14-16], GALA[17-19], TAT[20-22] and oligoarginine[23-26] are some of the commonly 
used peptide based materials for membrane destabilization. A shared feature among many 
CPPs is a helical secondary structure.[27,28]  In their helical conformation, CPPs have an 
amphipathic structure with both a hydrophobic and hydrophilic face that allows them to 
interact with and destabilize lipid bilayers such as cell and endosomal membranes.  When 
incorporated into delivery vectors, CPPs have been shown to lead to increased uptake, 
improved endocytic escape and overall better transfection efficiency.[29]  However, while 
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effective in promoting membrane destabilization as part of a larger vector, CPPs are often 
not optimized to function as standalone gene delivery agents.   
In Chapter 6, I report a strategy for the facile generation of cationic and helical 
polypeptides.[30] Typically, cationic polypeptides such as PLL are unable to adopt helical 
conformations at physiological pH due to side chain charge disruption.[31,32] However, 
our findings revealed that the helical structure of cationic polypeptides can be stabilized 
by increasing the hydrophobic interaction of the side chain, thus minimizing the effect of 
side chain charge repulsion (Figure 7.1).  The increase in hydrophobic interaction can be 
achieved by maintaining a minimum separation distance of 11 σ-bonds between the 
peptide backbone and the side chain charge.  By following this general strategy, it is 
possible to generate polypeptide materials which are high molecular weight (MW), 
positively charged and sufficiently high charge density to bind and condense DNA yet 
also retain the helical structure seen in many CPPs.  The unique combination of material 
properties afforded by the synthetic strategy described above allows us to examine 
helicity as a functional motif in the backbone of gene delivery vectors and evaluate its 
impact on transfection efficiency. 
 
 
 
 
 
Figure 7.1 Increased side chain length stabilizes polypeptide helix via increased hydrophobic 
interaction. 
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7.2 Materials and Methods 
7.2.1 General 
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) and used as 
received unless otherwise specified. VB-Glu-NCA was prepared and polymerized 
according to other published procedures1. Pierce BCA assay kits were purchased from 
ThermoFisher Scientific (Rockford, IL).  Luciferase assay reagent and Fugene HD was 
purchased from Promega (Madison, WI).  Lipofectamine 2000 (LFA) and the fluorescent 
dyes YOYO-1 and TAMRA-SE were purchased from Invitrogen (Carlsbad, CA). NMR 
spectra were recorded on a Varian UI400 MHz, a UI500NB MHz or a VXR-500 MHz 
spectrometer. Tandem gel permeation chromatography (GPC) experiments were 
performed on a system equipped with an isocratic pump (Model 1100, Agilent 
Technology, Santa Clara, CA), a DAWN HELEOS 18-angle laser light scattering 
detector (also known as multi-angle laser light scattering (MALLS) detector, Wyatt 
Technology, Santa Barbara, CA) and an Optilab rEX refractive index detector (Wyatt 
Technology, Santa Barbara, CA). The detection wavelength of HELEOS was set at 658 
nm.  Separations were performed using serially connected size exclusion columns (100 Å, 
500 Å, 103Å and 104 Å Phenogel columns, 5 µm, 300 × 7.8 mm, Phenomenex, Torrance, 
CA) at 60°C using DMF containing 0.1 M LiBr as the mobile phase. The MALLS 
detector is calibrated using pure toluene with no need for external polymer standards and 
can be used for the determination of the absolute molecular weights. The molecular 
weights (MWs) of all polymers were determined based on the dn/dc value of each sample 
calculated offline by using the internal calibration system processed by the ASTRA V 
software (version 5.1.7.3, Wyatt Technology, Santa Barbara, CA). Circular dichroism 
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(CD) measurements were carried out on a JASCO 720 CD Spectrometer. Ozone was 
produced by an OZV-8S ozone generator manufactured by Ozone Solutions Inc (Hull, 
IA). Lyophilization was performed on a FreeZone lyophilizer (Labconco, Kansas City, 
MO). COS-7, HEK293, MDA-MB-231 and HeLa cells were obtained from ATCC.  The 
cells were cultured according to their ATCC protocols at 37 °C and 5% CO2 in 
Dulbecco’s modified Eagle’s medium (DMEM). The growth medium was supplemented 
with 10 % fetal bovine serum and 1 % penicillin-streptomycin. Federally registered hESC 
line H9 was purchased from WiCell Research Institute and routinely maintained under 
feeder conditions. The expression vectors pCMV-Luc coding for the luciferase gene and 
pEGFP-N1 coding for green fluorescent protein were obtained from Elim 
Biopharmaceuticals (Hayward, CA). 
 
7.2.2 Synthesis of PVBLG-X (X = 1-31).   
Synthesis of Poly(γ-(4-aldehydebenzyl)-L-glutamate) (PABLG) is reported in Chapter 6. 
     
7.2.2.1 Method 1: Poly(γ-(4-aldehydebenzyl-L-glutamate) (20 mg, 0.08 mmol of 
aldehyde), amine (3-5 molar equivalents relative to the Glu repeating unit) and the 
reducing agent NaBH(OAc)3 (5-10 molar equivalents) were mixed in DMF (2 mL). The 
reaction mixtures were stirred at 50-60 oC for 24-48 h. The solution was then poured into 
3 M HCl (3 mL), followed by dialysis against water and lyophilization. (X = 1-5) 
 
7.2.2.2   Method 2: Poly(γ-(4-aldehydebenzyl-L-glutamate) (20 mg, 0.08 mmol of 
aldehyde) and amine (3-5 molar equivalents relative to the Glu repeating unit) were 
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stirred in DMF (2 mL) at 50-60 oC for 24h, followed by the addition of the reducing 
agent NaBH4 (5-10 molar equivalents). The resulting solutions were stirred at room 
temperature for another 24 h. The mixture were then poured into 3 M HCl (3 mL), 
followed by dialysis against water and lyophilization. (X = 6-7)) 
 
7.2.2.3  Method 3: Poly(γ-(4-aldehydebenzyl-L-glutamate) (20 mg, 0.08 mmol of 
aldehyde) and amine (3-5 molar equivalents relative to the Glu repeating unit) were 
stirred in DMF (2 mL) at 50-60 oC for 24h, followed by the addition of the reducing 
agent borane pyridine (5-10 molar equivalents). The resulting solutions were stirred at 
50-60 oC for another 24 h. The mixtures were then poured into 3 M HCl (3 mL), followed 
by dialysis against water and lyophilization. (X = 8-31) 
 
The yields of the products PVBLG-X (X = 1-31) were around 50-75% after dialysis.  
Grafting efficiencies were analyzed by 1H NMR integration and all of the polymer have 
grafting efficient around 90 % except for PVBLG-7 (70 % grafting density).   
 
7.2.3    General procedure for the analysis of polymer by circular dichroism (CD). 
Circular dichroism experiments were performed on a J-720 CD spectrometer. 
Polymer samples were prepared at concentrations of 0.05 mg/mL in DI water unless 
otherwise specified. The solution was placed in a quartz cell with light path of 0.5 cm. 
The mean residue molar ellipticity of each polymer was calculated based on the measured 
apparent ellipticity by following equations reported in literature: Ellipticity ([θ] in 
deg·cm2·dmol-1) = (millidegrees × mean residue weight)/(pathlength in millimeters × 
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concentration of polypeptide in mg/mL-1). Experiments were carried out at room 
temperature.  For pH-dependency studies, polymers were dissolved in buffer solutions at 
specific pH values. The background of the buffer was subtracted from each spectrum.   
 
7.2.4   Gel Retardation Studies 
A solution of DNA (1 µg/10 µL) was prepared in doubled distilled water.  
Appropriate amounts of PVBLGn-X (X = 1-9) dissolved in double distilled water were 
added to the DNA solution (10 µL) to achieve the desired PVBLGn-X:DNA weight ratio. 
Complexes were incubated at room temperature for 15 min, after which loading dye was 
added and the solution (10 µL) was run on a 1% agarose gel (70 V, 70 min). DNA was 
stained with ethidium bromide and visualized on a Gel Doc imaging system (Biorad, 
Herclues, CA).  
 
7.2.5      Complex Formation and Transfection 
DNA/polymer complexes were prepared at room temperature by dissolving DNA 
(0.35 µg) in 150 mM NaCl, 20 mM HEPES (175 µL). An equal volume of PLL, 25-kDa 
branched PEI or PVBLGn-X in 150 mM NaCl, 20 mM HEPES was added to achieve the 
desired weight ratio. The final complexes were incubated at room temperature for 15 min 
before further use. Cells (COS7, HEK293, MDA-MB-231 or HeLa) were cultured in 
DMEM supplemented with 10 % horse serum and 1 % penicillin-streptomycin according 
to ATCC protocols and plated in 96-well plates at 1 × 104 cells/well 24 h prior to 
transfection.  Immediately before transfection, the growth medium was replaced with 
fresh serum-free DMEM and polyplex solution (50 µL) was added to each well (0.05 µg 
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DNA/well). The transfection medium was replaced with fresh serum-supplemented 
growth medium 4 h post-transfection.  For studies involving drug treatment (methyl-β-
cyclodextrin at 10 mg/mL, chlorpromazine at 5 µg/mL, bafilomycin at 5 nM, nocodazole 
at 20 µM), cells were incubated with serum-free DMEM containing the drug 30 min prior 
to transfection. Luciferase expression was quantified 24 h post-transfection using the 
Promega Bright-Glo luciferase assay system (Promega, Madison, WI). Luciferase activity 
was measured in relative light units (RLU) using a PerkinElmer plate reader with 
luminescence capabilities (Waltham, MA). Results were normalized to total cell protein 
using the Pierce BCA protein assay kit (Rockford, IL). Transfections were performed in 
triplicate. 
 
 
7.2.6   Uptake study.  
DNA complexes were formed at their respective optimum transfection weight 
ratios as described above. The intercalating dye YOYO-1 was added at the ratio 15 nl 
YOYO-1 per 1 µg of DNA.  Cells (COS7 or HEK293) were cultured in DMEM 
supplemented with 10 % horse serum and 1 % penicillin-streptomycin according to 
ATCC protocols and plated in 24-well plates at 5 × 104 cells/well 24 h prior to 
transfection. Immediately before transfection, the growth medium was replaced with 
fresh serum-free medium and polyplex solution (50 µL) was added to each well (0.25 µg 
DNA/well). For studies involving drug treatment (methyl-β-cyclodextrin at 10 mg/mL, 
chlorpromazine at 5 µg/mL, bafilomycin at 5 nM or nocodazole at 20 µM), cells were 
incubated with DMEM containing the drug 30 min prior to transfection. Four hours post-
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transfection, the cells were rinsed with PBS (0.5 mL × 2) to remove surface-bound 
complexes.  Next, trypsin in PBS (0.05%, 100 µL) was added to each well. The cells and 
trypsin were incubated for approximately ten minutes before formaldehyde (4%, 400 µL) 
was added to each well.  The cells were then collected and FACS analyses were 
performed on a BD Biosciences LSR II flow cytometer (Franklin Lakes, NJ).  Data were 
analyzed using the FCS Express software package (De Novo Software, Los Angeles, 
CA).  Transfections and uptake measurements were performed in triplicate. 
 
 
7.2.7  Cytotoxicity Measurements.   
The cytotoxicity of the PVBLG-X polymers was characterized using the MTT 
cell viability assay (Sigma-Aldrich, St. Louis, MO).  Cells (COS7 or HEK293) were 
seeded in 96-wells plates at 1 × 104 cells/well and grown overnight at 37 °C, 5% CO2  in 
medium containing 10 % horse serum and 1 % penicillin-streptomycin. Approximately 
24 h after seeding the medium was replaced with serum-supplemented DMEM and the 
uncomplexed material was added to the cells at final concentrations between 0 and 50 
µg/mL.  After four hours of incubation, the medium was replaced with serum-containing 
medium and grown for another 20 h, after which reconstituted 3-[4,5-dimethylthiazol-2-
yl]-2,5-diphenyl tetrazolium bromide (MTT, 10 µL) was added.  The plates were then 
incubated for another four hours and MTT solubilization solution (100 µL, Sigma-
Aldrich, St. Louis, MO) was added and the absorbance at 570 nm was read using a 
PerkinElmer plate reader (Waltham, MA).  The background absorbance of cells killed 
with ethanol was subtracted from the viable cell absorbance and normalized to cells 
grown in DMEM.  Each experiment was repeated four times at each concentration. 
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7.2.8  Fluorescence Microscopy.  
DNA complexes were formed at the previously determined optimum transfection 
weight ratio as described above.  COS-7 and HEK293 cells were cultured in DMEM 
supplemented with 10 % horse serum and 1 % penicillin-streptomycin according to 
ATCC protocols and plated in 6-well plates containing coverslips at 20 × 104 cells/well 
24 h prior to transfection.  Immediately before transfection, the growth medium was 
replaced with fresh serum-free medium containing 250 nM calcein. PVBLG267-8 was 
added to cells at 0, 15 or 50 µg/mL.  Sixty minutes post-transfection, the cells were rinsed 
with PBS (2 mL × 2) to remove surface-bound complexes and formaldehyde (4 %, 1 mL) 
was added to each well.  Following a 10-min incubation, the cells were rinsed with PBS 
(2 mL × 2) and mounted on glass slides.  Cells were visualized with a Zeiss Axiovert 40 
CFL fluorescence microscope equipped with a 40 × objective. 
 
7.3 Results and Discussion 
7.3.1 Synthesis of PBVLG-X polymers.   
In this chapter, I report my efforts to develop a library of cationic α-helical 
polypeptides for gene delivery. The ring-opening polymerization of γ-(4-vinylbenzyl)-L-
glutamate N-carboxyanhydride (VB-Glu-NCA) was used to form poly(γ-(4-vinylbenzyl)-
L-glutamate) (PVBLG). PVBLG served as a reactive template that, through subsequent 
ozonolysis, and reductive amination, allowed me to create a library of cationic 
polypeptides (PVBLGn-X, where n is the degree of polymerization and X refers to the 
grafted amine side chain, Figure 7.2).  Due to its glutamate residues, PVBLG has a 
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propensity to adopt an α-helical secondary structure.[31-34] By maintaining a minimum 
separation distance of 11 σ-bonds between the peptide backbone and the side change 
charge, the PVBLGn-X polymers synthesized for this study have a helical structure that is 
stable over a broad range of pH values and salt concentrations.[30] It is hoped that the 
random incorporation of various structurally unique domains in the library will yield a 
selected few helical molecules with the appropriate balance of hydrophilicity (i.e. DNA 
binding strength) and hydrophobicity (i.e. endosomolysis) to mimic the membrane 
disruptive capabilities of CPPs yet also mediate efficient gene delivery without the 
addition of extraneous lytic materials. 
 
7.3.2 In vitro transfection and cconformation analysis of PBVLG-X polymers.   
The parallel synthetic scheme of Figure 7.2A was used to generate PVBLGn-X 
with 31 different amine side chains. The degree of polymerization was varied between 10 
and 267 for the top-performing amines. Of the various side chains, 15 showed improved 
performance relative to 22-kDa PLL and two (X = 1 and 8) showed improved 
performance relative to 25-kDa branched polyethylenimine (PEI) in COS-7 cells (Figure 
7.4). Generally speaking, transfection efficiency increased with increasing molecular 
weight. The top performing material, PVBLG267-8 with an aminoethyl piperidine side 
chain, resulted in the highest transfection efficiency—a 12-fold improvement over PEI.  
PVBLG267-8’s superior performance was confirmed in three additional cell lines 
(HEK293, MDA-MB-231, and HeLa) (Figure 7.5). Moreover, PVBLG267-8 showed 
reduced toxicity relative to PEI in COS-7 cells (Figure 7.6).  Circular dichroism (CD) 
confirmed that PVBLG267-8 maintained its helical conformation at physiological pH as 
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well as the acidic pH encountered within endosomes and lysosomes (Figure 7.3A). 
Moreover, the CD spectra also confirmed that the PVBLG-8 polymer maintained its 
helicity after biding with DNA at physiological condition. Figure 7.3C indicates there 
was no detectable helicity change of the PVBLGn-X before and after the formation of the 
polyplex with DNA in PBS, as elicited by comparing the θ (mdeg) value of “pDNA + 
PVBDLG150-8” and the “polyplex” at 222 nm.  
 
7.3.3 Mechanistic study and impact of secondary conformation on transfection.   
Since the PVBLGn-X polymers were designed to have an α-helical architecture 
similar to that found in peptides capable of disrupting membranes, we examined the 
ability of the polymers to cause pore formation in cell membranes. COS-7 cells were 
incubated with 250 µM calcein, a fluorescent dye, in the presence of various 
concentrations of PVBLG267-8. Calcein is unable to cross intact membranes.  Thus, in the 
absence of an agent capable of pore formation, calcein is taken up by cells in a pinocytic 
fashion, resulting in the appearance of small punctate intracellular fluorescent spots 
(Figure 7.7A, 0 µg/mL). However, as the amount of PVBLG267-8 in the extracellular 
medium is increased, the intracellular fluorescent signal becomes more diffuse, indicating 
transmembrane calcein uptake (Figure 7.7A, 50 µg/mL). The 15 µg/mL calcein 
concentration corresponds to the concentration of PVBLG267-8 used in the optimum 
transfection formulation. As indicated by the punctate fluorescent signals, complexes of 
PVBLG267-8 and DNA are unable to use pore formation for cell uptake. This is supported 
by flow cytometry data showing reduced complex uptake in the presence of various 
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endocytic inhibitors (Figure 7.8A). Similar results for calcein and complex uptake were 
observed for analogous experiments conducted in HEK293 cells (Figure 7.8C).  
 
Our results suggest that secondary structure can have a dramatic impact on the 
intracellular performance of polymer-based non-viral gene delivery vehicles. 
Specifically, the incorporation of helical architecture—a trait shared by many peptides 
capable of membrane disruption—into our gene delivery vector library yielded 
polypeptides which possess the ability to disrupt endosomes. Ultimately, this results in 
improved transfection performance of the polypeptides relative to random coil polymers 
like PLL and branched 25-kDa PEI. To directly demonstrate the importance of secondary 
structure, a random coil analogue of the top performing PVBLGn-8 polymer was 
synthesized using D- and L- VB-Glu-NCA monomers. The racemic configuration of 
amino acids (1:1 ratio) was confirmed to prevent the formation of secondary structure in 
the resulting PVB-D,L-G150-8 polymer by CD (Figure 7.7C). For comparison, helical 
PVB-L-G150-8 was also synthesized. Both polymers were used to transfect COS-7 cells 
over a variety of polymer:DNA weight ratios (Figure 7.7D). Confirming our speculations 
from cell penetration and drug inhibition data, the random coil PVB-D,L-G150-8 
polypeptide was unable to mediate effective transfection while helical PVB-L-G150-8 
was. The dramatic difference on transfection results stands as direct evidence that 
polymer secondary structure can impact its overall performance. 
 
To test the breadth of applicability of the helical polypeptides as gene delivery 
vehicles, PVBLG267-8 was used to transfect the H9 human embryonic stem cell (hESC) 
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line. hESCs are traditionally hard to transfect, with commercial agents often successfully 
delivering the transgene to less than 10 % of the treated cells.[39]  To explore if the 
enhanced membrane disruptive properties of PVBLG267-8 aided transfection in hard to 
transfect cells in addition to cells more amenable to gene delivery (i.e. COS-7 and 
HEK293 cells), H9 hESCs were transfected with a plasmid coding for green fluorescent 
protein (pEGFP-N1) and assayed for gene expression 48 hours post-transfection by flow 
cytometry. As nocodazole treatment was observed to aid transfection with PVBLG267-8, 
hESCs were also transfected in the presence and absence of nocodazole. In addition to 
PVBLG267-8, the commercial transfection agent lipofectamine 2000 (LFA) was also 
evaluated.  The transfection results can be seen in Figure 7.7E. Without the addition of 
nocodazole, PVBLG267-8 at a 20:1 PVBLG267-8:DNA weight ratio outperforms LFA by 
50 % and results in approximately 1.5 % of all hESCs expressing the transgene. The 
addition of 10 µM nocodazole to the transfection media increases the percentage of cells 
successfully transfected with PVBLG267-8 to roughly 4.5 %. This is approximately a 4-
fold enhancement over the transfection efficiency of LFA. 
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Figure 7.2 (A) Reaction scheme used to generate PVBLGn-X polypeptides; a. i) 
HMDS/TBA/DMF/nitrobenzene, ii) benzyl chloroformate/TBAF/DIPEA, 2h; b. i) O3/CHCl3, -
78°C, 1-5 min, ii) PPh3, rt, 2h; c. i) RNHR', NaBH(OAc)3, DMF/HOAc, 60°C, 24h, ii) HCl; d. i) 
RNHR', DMF/HOAc, 60°C, 16h, ii) BH3 pyridine complex, 8h, iii) HCl (B) Amine compounds 
used to synthesized PVBLGn-X for this study. 
 
125 
 
 
Figure 7.3  (A) Circular dichroism spectra of PVBLG267-8 in buffer at pH 2, 6 or 7.4. (B) 
Circular dichroism spectra of helical PVBLG150-8 and random coil PVBDLG150-8 in water. (C) 
Circular dichroism spectra of free plasmid DNA (0.05 mg/mL), free PVBLG150-8 (0.05 mg/mL), 
the numerical addition of the free DNA and PVBLG150-8 curves and polyplex formed by mixing 
plasmid DNA and PVBLG150-8 at a 1:1 weight ratio (concentration of DNA and PVBLG150-8 
were 0.05 mg/mL and 0.05 mg/mL after mixing). For comparison and simplicity reasons, the raw 
data instead of normalized spectra were shown.  
 
 
 
 
 
Figure 7.4  In vitro transfection COS-7 cells with PVBLGn-X polypeptides.   
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Figure 7.5 In vitro transfection of HeLa, MDA-MB-231 and HEK293 cells with 25-kDa 
branched PEI and the top-performing PVBLG267-8 polymer.  
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Figure 7.6  (A, left panel) Toxicity of some of the top-performing PVBLG267-X polymers in 
COS-7 cells. (B, right panel) Toxicity of some of the top-performing PVBLG267-X polymers in 
HEK293 cells. 
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Figure 7.7  (A) Calcein uptake in COS-7 cells treated with various concentrations of 
PVBLG267-8. (B) In vitro transfection of COS-7 cells transfected with complexes of 25-kDa PEI 
or PVBLG267-8 in the presence of intracellular processing inhibitors. (C) Circular dichroism 
spectra of helical PVB-L-G150-8 and random coil PVB-D,L-G150-8 in water. (D) In vitro 
transfection COS-7 cells with PVB-L-G150-8 and PVB-D,L-G150-8 polypeptides. 25-kDa PEI was 
included as a control. (E) In vitro transfection H9 human embryonic stem cells with PVBLG267-8 
in the presence and absence of 10 µM nocodozole and the commercial transfection agent 
lipofectamine 2000 (LFA). 
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Figure 7.8   (A) COS7 cell uptake of YOYO-1 labeled complexes formed with either 25-kDa 
PEI or PVBLG267-8 in the presence of endocytic inhibitors. (B) Normalized COS-7 cell uptake of 
YOYO-1 labeled complexes formed with either 25-kDa PEI or PVBLG267-8 in the presence of 
intracellular processing inhibitors. (C) HEK293 cell uptake of YOYO-1 labeled complexes 
formed with either 25-kDa PEI or PVBLG267-8 in the presence of endocytic inhibitors. (D) 
Normalized HEK293 cell uptake of YOYO-1 labeled complexes formed with either 25-kDa PEI 
or PVBLG267-8 in the presence of intracellular processing inhibitors. 
 
 
7.4 Conclusions 
The study reported here demonstrates the successful application of a library 
screening approach to the development of α-helical cationic peptides for gene delivery. 
To our knowledge, this is the first time a library approach has been combined with a 
reactive template bearing a well-defined and bioactive secondary structure. Our data 
indicate that certain library members retain the membrane destabilization properties 
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commonly associated with helical peptides and can be used to mediate effective gene 
delivery in a variety of cell lines, including immortalized cancer cells and hESCs. Vector 
helicity appears to be an essential component in the successful use of polypeptides for 
gene delivery. In view of the interesting properties of the reported class of helical cationic 
polypeptides, current studies are focused on developing high throughput strategies to 
further expand the library as well as exploring the potential for the material to mediate in 
vivo gene delivery as well as protein and siRNA delivery. 
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